Dipiro Status Report

Sample sent on: 21 Feb Sample Approved on : 26-Feb printer test sent on 26 March,13 printer test approved on : 28th
June Printer : CTPS CIP: MH will provide Printer date: tentative date is 4th Oct, 13 Copy editing : India Indexing: Thomson Proof reading India PE Chapt er Numb er DI PIRO STATUS REPORT
Batch No Section no
Section Name
Chapter No
Chapter Name
Editor name
Print/ Web
MSS
PE Typeset pages
Typeset Pages (Excluding Blanks)
Inputs Receipt Date
CE Start Date
CE Due Date
CE Received on
Page Proofs Due on
Sent to Author Sent to editor on on
1 1 Cardiovascular Disorders 2 4 10 19 3 21 22 23 24 25 27 28
Cardiovascular Testing Cardiac Arrest CHRONIC HEART FAILURE Stroke Gastroesophageal Reflux Disease Inflammatory Bowel Disease Nausea Vomiting Diarrhea, Constipation, andIrritable Bowel Syndrome Portal Hypertension and Cirrhosis Pancreatitis Celiac Disease Acute Kidney Injury
Talbert Talbert Talbert Talbert DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro Matzke
Print and Web Print Print Print Print Print Print Print Print Print Print
88 79 201 56 80 89 88 92 73 81 42
17 18 20 27 39 41 42 43 44 46 49
28 18 36 12 14 20 14 18 20 16 8
32 24 42 15 19 24 18 23 21 21 12
28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 31-Jan-13 12-Jan-13
10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 30-Jan-13
22-Jan-13 13-Feb-13 13-Feb-13 13-Feb-13 13-Feb-13 13-Feb-13 13-Feb-13 13-Feb-13 13-Feb-13 20-Feb-13 20-Feb-13 20-Feb-13
23-Jan-13 31-Jan-13 12-Feb, 13 31-Jan-13 9-Feb 8-Feb 12-Feb, 13 12-Feb, 13 19-Feb, 13 12-Feb 26-Feb
15 March, 13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 2-Apr-13 15-Mar-13
15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 2-Apr-13 15-Mar-13
15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 2-Apr-13 15-Mar-13
Gastrointestinal Disorders
Print
94
51
26
27
14-Jan-13
21-Feb
Renal Disorder
29 Chronic Kidney Disease: Management of Complications Hemodialysis and Peritoneal Dialysis Disorders of Potassium and Magnesium Homeostasis AcidBase Disorders
Matzke Print Print Print Print 145 94 63 89 53 54 60 61 20 18 14 20 35 25 18 25 15 Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print 63 66 72 66 49 79 94 111 69 62 99 93 197 80 60 76 57 66 67 72 73 90 114 115 116 117 118 119 120 121 122 124 125 127 12 14 14 12 8 12 20 22 14 12 20 18 20 18 14 16 12 19 17 17 14 17 24 25 17 16 30 22 24 18 19 21 17
12-Jan-13 14-Jan-13 14-Jan-13 14-Jan-13 14-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 10-Jan-13 20-Feb-13 20-Feb-13 20-Feb-13 20-Feb-13 20-Feb-13 20-Feb-13 15th march 15th march 15th march 15th march 15th march 15th march 15th march 24th March 24th March 24th March 24th March 24th March 15th march 15th march 15th march 22-Feb 25-Feb 28-Feb 28-Feb 2-Mar 4-Mar 14-Mar 14-Mar 16-Mar 18-Mar 20-Mar 22-Mar 25-Mar 25-Mar 1-Mar 8-Mar 12-Mar 24-Feb-13 19-Feb 20-Feb 21-Feb 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 2-Apr-13 2-Apr-13 3-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 3-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13
15-Mar-13
15-Mar-13
30 36 37 5 1 6 8 Psychiatric Disorders Gynecologic and Obstetric Disorders Neurologic Disorders 41 42 46 47 64 83 84 85 86 87 88 89 90 91 15 Infectious Diseases 93 94 96
Matzke Matzke Matzke Wells
12-Jan-13 12-Jan-13 12-Jan-13 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12
15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 2-Apr-13 2-Apr-13 3-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 3-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13
15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 15-Mar-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13
Status Epilepticus ACUTE MANAGEMENT OF THE BRAIN INJURY PATIENT Attention Deficit Hyperactivity Disorder Eating Disorders Endometriosis Antimicrobial Regimen Selection Central Nervous System Infections Lower Respiratory Tract Infections Upper Respiratory Tract Infections Influenza Skin and Soft-Tissue Infections Infective Endocarditis Tuberculosis Gastrointestinal Infections and Enterotoxigenic Poisonings Parasitic Diseases Urinary Tract Infections and Prostatitis Bone and Joint Infections
Wells Wells Wells Wells DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro
99 Invasive Fungal Infections
DiPiro Print 168 130 32 37
28-Dec-12
10-Jan-13
15th march
15-Mar 2-Apr-13 2-Apr-13 2-Apr-13
100 17 Nutritional Disorders 101 120
Infections in Immunocompromised Patients Antimicrobial Prophylaxis in Surgery Enteral Nutrition
DiPiro DiPiro Matzke
Print Print Print
139 78 152 3384
131 132 79
26 16 20
32 19 22
28-Dec-12 28-Dec-12 12-Jan-13
10-Jan-13 10-Jan-13 14-Jan-13
15th march 15th march 15th march
18-Mar 19-Mar 20-Mar
3-Apr-13 2-Apr-13 2-Apr-13
3-Apr-13 2-Apr-13 2-Apr-13
2-Apr-13 2-Apr-13 2-Apr-13
Cardiovascular Disorders
13 Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock Alzheimers disease Multiple Sclerosis Epilepsy Parkinsons Disease PAIN MANAGEMENT Headache Disorders Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine Schizophrenia Major Depressive Disorder Bipolar Disorder Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder SLEEP DISORDERS
Talbert
Neurologic Disorders
38 39 40 43 44 45 48 49 50 51 52
Wells Wells Wells
Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells
Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print
69 102 95 30 62 94 43 66 90 64 110 65 102 63 54
30 63 64 65 68 69 70 74 75 76 77 78 79 80 81 18
22 16 16 28 12 16 17
22 25 32 17 22 20 22
11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13
20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13
5-May-13 26-Mar-13 26-Mar-13 26-Mar-13 26-Mar-13 26-Mar-13 17-Apr-13 17-Apr-13 17-Apr-13 17-Apr-13 17-Apr-13 17-Apr-13 17-Apr-13 17-Apr-13 17-Apr-13
3-Jun-13 25-Mar-13 25-Mar-13 29-Mar-13 26-Mar-13 30-Mar-13 30-Mar-13 5-Apr-13 3-Apr-13 11-Apr-13 6-Apr-13 9-Apr-13 25-Apr-13 25-Apr-13 25-Apr-13
7-Jun-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13
7-Jun-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13
7-Jun-13
14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13 14-May-13
16 26 18 18 20 12 12
21 32 24 19 24 15 16
Psychiatric Disorders
53 54 55 56
57 58
Disorders Associated with Intellectual Disabilities ENDOCRINOLOGIC DISORDERS
Talbert Talbert
Print Print
70 166
82 83
16 48
20
11-Mar-13 11-Mar-13
20-Mar-13 20-Mar-13
5-May-13 5-May-13
22-Apr-13 17-May-13
1-May-13 7-Jun-13
30-Apr-13
7-Jun-13
30-Apr-13
7-Jun-13
Thyroid Disorders 7 Endocrinologic Disorders 59 Adrenal Gland Disorders 60 61 Pituitary Gland Disorders Pregnancy and Lactation: Therapeutic Considerations Talbert Wells Talbert
Print
112
84
24
11-Mar-13
20-Mar-13
5-May-13
21-May-13
7-Jun-13
7-Jun-13
7-Jun-13
Print Print Print
83 41 94
85 86 87
18 16 16
24
11-Mar-13 11-Mar-13 11-Mar-13
20-Mar-13 20-Mar-13 20-Mar-13
5-May-13 5-May-13 5-May-13
25-Apr-13 28-May-13 31-May-13
17-May-13 7-Jun-13 7-Jun-13
17-May-13 7-Jun-13 7-Jun-13
17-May-13 7-Jun-13 7-Jun-13
62 8 Gynecologic and Obstetric 63 65 66 67 68 71 74 75 76 3 5 1 Cardiovascular Disorders 8 9 14 17 18 31 32 Hormone Therapy in Women Erectile Dysfunction Benign Prostatic Hyperplasia Urinary Incontinence Osteoarthritis Gout and Hyperuricemia Glaucoma Allergic Rhinitis Hypertension Acutely Decompensated Heart Failure Arrhythmias Venous Thromboembolism Hypovolemic Shock Pulmonary Artery Hypertension Cystic Fibrosis Drug-Induced Kidney Disease Glomerulonephritis Contraception Menstruation-Related Disorders
Wells wells Wells Posey Posey Posey Posey Posey Posey Posey Talbert Talbert Talbert Talbert Talbert Talbert Talbert
Matzke Matzke
Print Print
81 77
88 89
16 16
11-Mar-13 11-Mar-13
20-Mar-13 20-Mar-13
5-May-13 5-May-13
1-Jun-13 18-May-13
7-Jun-13 7-Jun-13
7-Jun-13 7-Jun-13
7-Jun-13 7-Jun-13
9 11 12
Urinary Incontinence Rheumatologic Disorders OPHTHALMIC AND OTOLARYNGOLOGICAL DISORDERS
Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print
116 128 91 106 102 92 65 77 181 96 131 138 79 48 88 96 97
91 92 93 94 101 102 103 104
20 18 12 20 22 12 16 12
11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13
20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 20-Mar-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13
5-May-13 9-May-13 9-May-13 7-Apr-13 7-Apr-13 7-Apr-13 7-Apr-13 7-Apr-13 26-Jun-13 26-Jun-13 26-Jun-13 26-Jun-13 26-Jun-13 26-Jun-13 26-Jun-13 28-Jun-13 28-Jun-13
21-May-13 23-May-13 8-Apr-13 9-Apr-13 10-Apr-13 11-Apr-13 11-Apr-13 13 June, 13
7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 10-Jul-13 10-Jul-13 10-Jul-13 10-Jul-13 10-Jul-13 10-Jul-13 10-Jul-13 10-Jul-13 10-Jul-13
7-Jun-13 10-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13
7-Jun-13 10-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13
15-Jun-13
Respiratory Disorders
20-Jun-13
26-Jun-13
Renal Disorders
Renal Disorders
10 14
Immunologic Disorders Hematologic Disorders
33 34 35 69 70 80 81 82 92 95 97 98 102 103 104 105 106
Drug Therapy Individualization for Patients with Renal Insufficiency Disorders of Sodium and Water Homeostasis Calcium and Phosphorus Homeostatis Systemic Lupus Erythematosus Solid Organ Transplantation Anemias
Matzke Matzke Matzke
Coagulation Disorders
Sickle cell anemia Intra-abdominal Infections Sexually Transmitted Diseases Severe Sepsis and Septic Shock Superficial Fungal Infections Vaccines, Toxoids, and Other Immunobiologics Human Immunodeficiency Virus Cancer Treatment and Chemotherapy Breast Cancer Lung Cancer Total Ischemic Heart Disease Acute Coronary Syndromes Peripheral Arterial Disease Asthma Chronic Obstructive Pulmonary Disease PepticUlcerDisease Viral Hepatitis RheumatoidArthritis Osteoporosis and Osteomalacia Acne Vulgaris Psoriasis Atopic Dermatitis Colorectal Cancer Prostate Cancer Lymphomas Ovarian Cancer Acute Leukemias Chronic Leukemias Multiple Myeloma Myelodysplastic Syndrome Renal Cell Carcinoma Melanoma Hematopoietic Stem Cell Transplantation Assessment of Nutrition Status and Nutrition Requirements Parenteral Nutrition Obesity Total Health literacy
Yee Matzke Yee Yee Yee DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro Yee Yee Yee
Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print
86 95 86 75 107 88 82 89 84 116 70 95 94 112 200 183 76 2692 141 147 45 168 105 132 103 73 147 19 67 49 149 80 128 65 101 81 90 93 65 92 99 110 94 96 2539 79 32 57 128 83 65 58 68 53 95
9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13
5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13 5-Jun-13
28-Jun-13 28-Jun-13 28-Jun-13 25-Jul-13 28-Jun-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13 25-Jul-13
27-Jun-13
10-Jul-13 10-Jul-13 10-Jul-13 9-Aug-13 10-Jul-13 24-Jul-13 3-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13
15
Infectious Diseases
16
Oncologic Disorders
Cardiovascular Disorders
Respiratory Disorders Gastrointestinal Disorders
11
Rheumatologic Disorders
16
Oncologic Disorders
6 7 12 15 16 20 26 72 73 77 78 79 107 108 109 110 111 112 113 114 115 116 117 118 119 121 W1 W2 W3 W4 W5 W6 W7 W8 W9 W10
Talbert Talbert Talbert Talbert Talbert DiPiro DiPiro Posey Posey Posey Posey Posey Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Matzke Matzke Matzke No input Posey Posey Posey Posey Posey Posey Posey Posey Matzke posey/Matzke
Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print Print
22-May-13 22-May-13 22-May-13 22-May-13 29-May-13 30-May-13 29-May-13 29-May-13 29-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13
12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 11-Jun-13 11-Jun-13
26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 25-Jul-13 25-Jul-13
9-Aug-13 23-Jul-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13 9-Aug-13
17
Nutritional Disorders
Cultural Competency
Principles and Practices of Medication Safety Evidence-Based Medicine Clinical Pharmacokinetics and Pharmacodynamics Pharmacogenetics Pediatrics Geriatrics Palliative Care Clinical Toxicology Emergency Preparedness and Response: Biologic Exposures
WS1
Foundation Issues
W11 W12 w14 (W13) W15(W14) W16(W15) w17(W16) w18(W17) w19(W18) Organ-Specific Function Tests w20 (W19) and Drug-Induced Diseases w21(W20) w22(W21)
Posey/Matzke Emergency Preparedness: Identification and Management of Chemical and Radiological 82 Exposures Talbert Pulmonary fct testing Drug-Induced Pulmonary Diseases Eval GI tract liver disease Evaluation of Kidney Function EVALUATION OF NEUROLOGIC ILLNESS Evaluation of Mental Illness Immune system Allergic and Pseudoallergic Drug Reactions Talbert DiPiro DiPiro Matzke Wells Wells Yee Yee 93
95 28 69 84
Organ-Specific Function Tests and Drug-Induced Diseases Posey Yee DiPiro
w23(W22) w24(W23) w25(W24)
Dermatologic Drug Reactions and Common Skin Conditions Drug-Induced Hematologic Disorders Lab test antimicrobial ptherapy Total
42 72 1242
Proof Corrections due Proof corrections actually to receive from received from Author Author
Proof Proof corrections Corrections due actually received to receive from from editor editor
Proof correction Page Proofs s actually received for LO/ received MCQ from mcgraw hill Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Revised proofs and index (By TD) proofs to McGraw-Hill due on
Revised pages actually sent on
Final Printer Files due to McGrawHill
Final Printer Files to mcgrawhill actually sent on
Final XML Files Sent Remarks on
22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 9-Mar-13
26-Mar-13 20-Mar-13 22-Mar-13 18-Mar-13 26-Mar-13 2-Apr-13 18-Mar-13 26-Mar-13 22-Mar-13 22-Mar-13 8-Apr-13
2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 23-Apr-13 2-Apr-13
2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 19-Apr-13
27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13
schedule is changed as per Editor's confirmation (March 9 - 16)
11-Jun 11-Jun 15-Jun 15-Jun 11-Jun 15-Jun 15-Jun 11-Jun
22-Mar-13
11-Apr-13
18-Apr-13
Yes
27-May-13
18-Jun
2-Apr-13 22-Mar-13 22-Mar-13 22-Mar-13 22-Mar-13 26-Mar-13 23-Mar-13 20-Mar-13 19-Mar-13 Comments recived directly from editor 22-Mar-13 3-Apr-13 9-Apr-13 23-Apr-13 11-Apr-13 12-Apr-13 12-Apr-13 9-Apr-13 10-Apr-13 16-Apr-13 11-Apr-13 14-Apr-13 14-Apr-13 3-Apr-13 6-Apr-13 4/9/2013 and 10-April-13 I returned them to Dr. DiPiro last week and he acknowledged receipt of my edits.
1-Apr-13 Yes Yes Yes Yes Yes/ MCQ received on 22 April Yes Yes Yes
27-May-13 27-May-13 27-May-13 27-May-13
2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 2-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13 23-Apr-13
1-Apr-13 1-Apr-13 1-Apr-13 28-Mar-13 22-Mar-13 4-Apr-13 9-Apr-13 29-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13 19-Apr-13
15-Jun
27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13 27-May-13
22-Mar-13 22-Mar-13 9-Apr-13 9-Apr-13 1-May-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 15-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13
15-Jun 18-Jun 15-Jun 15-Jun 20-Jun 15-Jun 20-Jun 18-Jun 20-Jun schedule changed/ author will send correction to editor by April 15 20-Jun 18-Jun 20-Jun 15-Jun copy Rocsanna.Namdar@ucdenver.edu also
Yes Yes Yes yes Yes Yes Yes yes Yes Yes Yes Yes
23-Apr-13 19-Apr-13 Yes

27-May-13
9-Apr-13
15-Apr-13 9-Apr-13 9-Apr-13
16-Apr-13 7-Apr-13 10-Apr-13
23-Apr-13 23-Apr-13 23-Apr-13
19-Apr-13 19-Apr-13 12-Apr-13
Yes Yes Yes
27-May-13 27-May-13 27-May-13
schedule changed/ author will send correction to editor by April 15 20-Jun
14-Jul-13 21-May-13 21-May-13 21-May-13 21-May-13 21-May-13 21-May-13 21-May-13 21-May-13 21-May-13 29-May-13 24-May-13 21-May-13 21-May-13 21-May-13
12-Jun 22-May-13 30-May-13 23-May-13 21-May-13 22-May-13 31-May-13 21-May-13 22-May-13 12-Jun-13 30-May-13 6-Jun-13 23-May-13 25-May-13 29-May-13
28-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13
13-Jun 24-May-13 5-Jun-13 27-May-14 21-May-13 27-May-14 5-Jun-13 22-May-13
yes yes yes yes yes yes yes yes
29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13
We will send you e-proofs as it is the most convenient and fast mode of transferring files. Shipping hard copy proofs takes time. Since you are away end of June through about July 10th, we will be sending the Page proofs of your chapter to you on 7th June and you can return your comments/corrections to Dr.
23-May-13 yes 19-Jun yes 14-Jun yes 28-May-13 yes 27-May-14 yes 4-Jun-13 yes
same authors for bpth chapters, so we need to send one mail for both
8-May-13 14-Jun-13
8-May-13
7-Jun-13 28-Jun-13
14-Jun-13
12-Jun-13
28-Jun-13
24-May-13 yes 20-Jun yes yes (No comments for 13-Jun-13 SA)
29-Jul-13 29-Jul-13
We will try to send you page proofs of your chapter by 1st May if possible, else you can take one more week and can send your comments to Dr. Wells by 28th May instead of 21st May.
29-Jul-13
24-May-13 14-Jun-13 14-Jun-13
22-May-13 15-Jun-13 15-Jun-13
28-Jun-13 28-Jun-13 28-Jun-13
29-May-13 no yes (AU correx 15-Jun-13 for SA) 19-Jun-13 yes
29-Jul-13 29-Jul-13 29-Jul-13
We will send you page proofs of your chapter by 17th May and you need to return corrections/comments by 24th May. Please let us know if it is fine with you.
18-Jun-13 14-Jun-13
18-Jun-13 14-Jun-13
28-Jun-13 28-Jun-13
21-Jun yes 15-Jun-13
29-Jul-13 29-Jul-13
Thanks for letting us know your updated email address and your plans during this time. We will try to send page proofs of your chapter early if possible. Else since you are not available from 11th June - 14th June, you can take 3-4 days extra and return your corrections/comments for page proofs of your
14-Jun-13 14-Jun-13 14-Jun-13 11-Jul-13 14-Jun-13 14-Jun-13 14-Jun-13 14-Jun-13

23-Jul-13 17-Jul-13 17-Jul-13 17-Jul-13 17-Jul-13 17-Jul-13 17-Jul-13 17-Jul-13 17-Jul-13
14-Jun 17-Jun 14-Jun
12-Jun-13 10-Jun-13 26-Jun-13
28-Jun-13 28-Jun-13 28-Jun-13 28-Jun-13 28-Jun-13 28-Jun-13 28-Jun-13 28-Jun-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13
20-Jun yes 24-Jun yes 24-Jun yes
24-Jun yes
29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 29-Jul-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13
SophiaKalantaridou <sophiakalantaridou@gmail.com>/ Hard Copy to be sent
Thanks for letting us know that you are not available during the This will work for me. Thank you.
Need to send hard copy proof to one of the authors "Cynthia"
17-Jul-13 22-Jul-13 17-Jul-13 17-Jul-13 31-Jul-13 10-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13
31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 31-Jul-13 30-Aug-13 31-Jul-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13
6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13
Email Address has been changed to alan.edward.gross@gmail.com
16-Aug-13 30-Jul-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 23-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 23-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13 16-Aug-13
30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13 30-Aug-13
6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13 6-Sep-13
Hard copy to be sent to Christine A. Sorkness
CE- Pooja Mittal and Ananth Batch 1 Cast Off Chapter 1 (Sample) Chapter 2,4,10,19, 21 to 24 25, 28 and 29. 30, 36, 37, 41 and 42 27,46, 47, 64, 83-91 93,94,96,99-101, 120 Due Date 22-Jan 13-Feb 20-Feb 20-Feb 15-Mar 15-Mar 3060
Pooja Pooja Ananth Pooja Ananth Batch 2
Cast Off CE Ananth Ananth Pooja Pooja Ananth Chapters 38, 39, 40, 43, 44 68, 71, 74, 75 and 76 45, 48- 55 57 and 58 13, 63, 65, 66 and 67, 60 to 62
2697 Due Dates Pages 26-Mar 289 7-Apr 442 17-Apr 657 25-May 20-May
Page Proof Date for Chapter 56 is 17-May-13
Actual Date 23-Jan 12-Feb 12-Feb 25-Feb 24-Mar 21-Mar
Pages Remaining for CE Page Proofs Date

14-May-13 7-Jun-13 14-May-13 7-Jun-13 7-Jun-13
391
Status all chapters received all chapters received 3 Chapters left
EDITOR PREFERENCE SHEET

EDITOR NAME
Joseph DiPiro
SCHEDULE SHARED ON
COMMENTS
1/22/2013
Robert Talbert
schedule confirmed
Gary Yee Gary Matzke
1/22/2013 schedule confirmed 1/8/2013- introduction mail only
1/22/2013
schedule confirmed
Barbara Wells
1/24/2013
schedule confirmed
L. Michael Posey
1/8/2013- introduction mail only
OR PREFERENCE SHEET
MODE OF DELIVERY SHIPPING ADDRESS EMAIL ADDRESS
jdipiro@sccp.sc.edu
e-proofs only
NA talbert@uthscsa.edu Dr. Robert L. Talbert, Pharm. D., FCCP, BCPS, FAHA, Pharmacotherapy Education & Research Center (PERC), UTHSCSA - PERC , 7703 Floyd Curl Drive MC 6220, San Antonio, TX 78229-3900 , U.S. Office Phone: 210-567-8318 , Cell: 210-884-3291 gcyee@unmc.edu
hardcopy only e-proofs only
gmatzke@vcu.edu
e-proofs and hardcopy both
Dr. Gary Matzke, 925 Roll Drive, Midlothian, Virginia 23114 USA.
e-proofs only
bwellspharm@gmail.com
lmposey@mac.com e-proofs only NA
Remarks
The author of Chapter 27, Celiac disease has informed me that he wishes to make more changes. Please hold off on preparing page proofs for this chapter until I submit the revised chapter.
Use Chapter title and numbers
want to be copied on all of your correspondence with authors of chapters in his sections. Please note that I have chapters in two other sectionschapters w10,w11, w12, w17 and chapter 70. I neglected to let you know that I will be at a professional want to be copied on all of meeting (with a little your correspondence with vacation tagged onto the end authors of chapters in her from April 20th through sections. wants contributors about April 29th or 30th. So, of her chapters review page I will try very hard to wrap up proofs via e-proofing this process before I leave. Hopefully, my contributors will cooperate.
call Micheal only
Serial No. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
9/e Ch. # W1 W1 W3 W4 W5 W6 W7 W8 W9 W10 W11 W12 W13 W14 W15 W16 W17 W18 W19 W20 W21 W22 W23 W24 W25
Received Chapter Title Foundation Issues Health Literacy Health Literacy Medication Safety Evidence-Based Medicine Pharmacokinetics Pharmacogenetics Pediatrics Geriatrics Palliative Care Clinical Toxicology Biological Terrorism Chemical and Radiological Terrorism Organ-Specific Function Tests and Drug-Induced Diseases yes Cardiovascular Testing Pulmonary Function Testing Drug-Induced Pulmonary Disease Evaluation of the Gastrointestinal Tract Drug-Induced Liver Disease Quantification of Renal Function Evaluation of Neurological Illness Evaluation of Psychiatric Illness Function and Evaluation of the Immune System Allergic and Pseudoallergic Drug Reactions Dermatologic Drug Reactions, Self-Treatable Skin Disorders, and Skin Cancer Drug-Induced Hematologic Disorders Laboratory Tests to Direct Antimicrobial Pharmacotherapy Section- 1 Cardiovascular Disorders Cardiovascular Testing Cardiopulmonary Arrest Hypertension Chronic Heart Failure Acutely Decompensated Heart Failure Ischemic Heart Disease Acute Coronary Syndromes Arrhythmias Venous Thromboembolism Stroke Hyperlipidemia Peripheral Arterial Disease Use of Vasopressors and Inotropes in Pharmacotherapy of Shock
26 27 28 29 30 31 32 33 34 35 36 37 38
1 2 3 4 5 6 7 8 9 10 11 12 13
yes yes yes yes yes yes yes yes yes yes yes yes
39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74
14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Hypovolemic Shock Section- 2 Respiratory Disorders Asthma Chronic Obstructive Pulmonary Disease Pulmonary Artery Hypertension Cystic Fibrosis Section- 3 Gastrointestinal Disorders Gastroesophageal Reflux Disease Peptic Ulcer Disease Inflammatory Bowel Disease Nausea and Vomiting Diarrhea, Constipation, and Irritable Bowel Syndrome Portal Hypertension and Cirrhosis Pancreatitis Viral Hepatitis Celiac Disease Section- 4 Renal Disorders Acute Renal Failure Chronic Kidney Disease: Progression-Modifying Therapies Hemodialysis and Peritoneal Dialysis Drug-Induced Kidney Disease Glomerulonephritis Drug Therapy Individualization for Patients with Renal Insufficiency Disorders of Sodium and Water Homeostasis Calcium and Phosphorus Homeostatis Potassium and Magnesium Homeostasis Acid-Base Disorders Section- 5 Neurologic Disorders Alzheimer's Disease Multiple Sclerosis Epilepsy Status Epilepticus Acute Management of the Brain Injury Patient Parkinson's Disease Pain Management Headache Disorders Section-6 Psychiatric Disorders Attention-Deficit/Hyperactivity Disorder Eating Disorders Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
yes yes yes yes yes yes yes yes yes yes yes yes yes
yes
29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes
75 76 77 78 79 80 81 82 83 84 85
50 51 52 53 54 55 56 57 58 59 60
Schizophrenia Depressive Disorders Bipolar Disorder Anxiety Disorders I: Generalized Anxiety Disorder, Panic, and Social Anxiety Disorders Anxiety Disorders II: Posttraumatic Stress Disorder and Obcessive-Compulsive Disorder Sleep Disorders Developmental Disabilities Section- 7 Endocrinologic Disorders Diabetes Mellitus Thyroid Disorders Adrenal Gland Disorders Pituitary Gland Disorders Section- 8 Gynecologic and Obstetric Disorders
yes yes yes yes yes yes yes yes yes yes yes yes
86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108
61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83
Pregnancy and Lactation Contraception Menstrual-Related Disorders Endometriosis Hormone Therapy in Women Section- 9 Urologic Disorders Erectile Dysfunction Benign Prostatic Hyperplasia Urinary Incontinence Section- 10 Immunologic Disorders Systemic Lupus Erythematosus Solid Organ Transplantation Section- 11 Rheumatologic Disorders Osteoarthritis Rheumatoid Arthritis Osteoporosis and Osteomalacia Gout and Hyperuricimia Section- 12 Ophthalmic and Otolaryngological Disorders Glaucoma Allergic Rhinitis Section-13 Dermatologic Disorders Acne Vulgaris Psoriasis Atopic Dermatitis Section- 14 Hematologic Disorders Anemias Coagulation Disorders Sickle cell anemia Section- 15 Infectious Diseases Antimicrobial Regimen Selection
yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes
109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117
Central Nervous System Infections Lower Respiratory Tract Infections Upper Respiratory Tract Infections Influenza Skin and Soft Tissue Infections Infective Endocarditis Tuberculosis Gastrointestinal Infections and Enterotoxigenic Poisonings Intra-abdominal Infections Parasitic Diseases Urinary Tract Infections Sexually Transmitted Diseases Bone and Joint Infections Sepsis and Septic Shock Superficial Fungal Infections Invasive Fungal Infections Infections in Immunocompromised Patients Antimicrobial Prophylaxis in Surgery Vaccines, Toxoids, and Other Immunobiologics Human Immunodeficiency Virus Section- 16 Oncologic Disorders Cancer Treatment and Chemotherapy Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Lymphomas Ovarian Cancer Acute Leukemias Chronic Leukemias Multiple Myeloma Myelodysplastic Syndromes Renal Cell Carcinoma Melanoma Hematopoietic Stem Cell Transplantation Section- 17 Nutritional Disorders Assessment of Nutrition Status and Nutrition Requirements Parenteral Nutrition Enteral nutrition Obesity
yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes
118 119 120 121
yes yes yes yes
Editor
Posey/Talbert Posey/Talbert Posey Posey Posey Posey Posey Posey Posey Matzke Posey
Batch no
Received on
Posey
Talbert Talbert
28-Dec-12
Talbert
DiPiro DiPiro Matzke Wells
Wells Yee Yee Posey Yee DiPiro
Talbert Talbert Talbert Talbert Talbert Talbert Talbert Talbert Talbert Talbert Talbert Talbert Talbert
1 1 3 1 3 4 4 3 3 1 4 2
28-Dec-12 28-Dec-12 9-Apr-13 28-Dec-12 9-Apr-13 22-May-13 22-May-13 9-Apr-13 9-Apr-13 28-Dec-12 22-May-13 11-Mar-13
Talbert Talbert Talbert Talbert Talbert DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro
Matzke Matzke
3 4 4 3 3 1 4 1 1 1 1 1 4
9-Apr-13 22-May-13 29-May-13 9-Apr-13 9-Apr-13 28-Dec-12 30-May-13 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 29-May-13
12-Jan-13
Matzke Matzke Matzke Matzke Matzke Matzke Matzke Matzke Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells Wells
1 1 3 3 3 3 3 1 1 2 2 2 1 1 2 2 2 1 1 2 2
12-Jan-13 12-Jan-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 12-Jan-13 12-Jan-13 11-Mar-13 11-Mar-13 11-Mar-13 28-Dec-12 28-Dec-12 11-Mar-13 11-Mar-13 11-Mar-13 28-Dec-12 28-Dec-12 11-Mar-13 11-Mar-13
Wells Wells Wells Wells Wells Wells Wells Talbert Talbert Talbert Talbert/ Matzke
2 2 2 2 2 2 2 2 2 2 2 2
11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13
Wells Wells Wells Wells Wells Posey Posey Posey
2 2 2 1 2 2 2 2 3 3 2 4 4 2 2 2 4 4 3 3 3 1
11-Mar-13 11-Mar-13 11-Mar-13 28-Dec-12 11-Mar-13 11-Mar-13 11-Mar-13 11-Mar-13 9-Apr-13 9-Apr-13 11-Mar-13 29-May-13 29-May-13 11-Mar-13 11-Mar-13 11-Mar-13 22-May-13 22-May-13 9-Apr-13 9-Apr-13 9-Apr-13 28-Dec-12
Yee
Matzke Posey Posey Posey Posey Posey Posey Posey Posey Posey
Yee Yee Yee

DiPiro
DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro DiPiro Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Yee Matzke Matzke Matzke Matzke
1 1 1 1 1 1 1 1 3 1 1 3 1 3 3 1 1 1 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 4
28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 28-Dec-12 9-Apr-13 28-Dec-12 28-Dec-12 9-Apr-13 28-Dec-12 9-Apr-13 9-Apr-13 28-Dec-12 28-Dec-12 28-Dec-12 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13 22-May-13
4 4 1 4
22-May-13 22-May-13 12-Jan-13 22-May-13
Chapter No 1 2 4 10 19 21 22 23 24 25 27 28 Cardiovascular Testing Cardiac Arrest
Chapter Name
Algorithms
No. of Algorithms
No
CHRONIC HEART FAILURE Stroke Gastroesophageal Reflux Disease Inflammatory Bowel Disease Nausea Vomiting Diarrhea, Constipation, andIrritable Bowel Syndrome Portal Hypertension and Cirrhosis Pancreatitis Celiac Disease Acute Kidney Injury
Yes Yes No No Yes No Yes Yes Yes No Yes
2 0 0 0 2 0 3 3 4 0 2
29
Chronic Kidney Disease: Progression-Modifying Therapies
30 36 37 41
Hemodialysis and Peritoneal Dialysis Disorders of Potassium and Magnesium Homeostasis AcidBase Disorders Status Epilepticus
Yes Yes Yes Yes Yes
5 2 1 3 1
42
ACUTE MANAGEMENT OF THE BRAIN INJURY PATIENT
Yes
46 Attention Deficit Hyperactivity Disorder
Yes
47 Eating Disorders
Yes
64 83 84 85 Endometriosis Antimicrobial Regimen Selection Central Nervous System Infections Lower Respiratory Tract Infections
1 1 0 1
Yes No Yes
Yes
86 87
Upper Respiratory Tract Infections Influenza
No No
0 0
88
Skin and Soft-Tissue Infections
89 90 91 93 94 96 99
Infective Endocarditis Tuberculosis Gastrointestinal Infections and Enterotoxigenic Poisonings Parasitic Diseases Urinary Tract Infections and Prostatitis Bone and Joint Infections Invasive Fungal Infections
Yes No No No No Yes No Yes
2 0 0 0 0 2 0 1
100
Infections in Immunocompromised Patients
101 120
Antimicrobial Prophylaxis in Surgery Enteral Nutrition
Yes No No
2 0 0
13 38 39 40 43 44
Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock Alzheimers disease Multiple Sclerosis Epilepsy Parkinsons Disease
Yes NO Yes Yes Yes
1 NA 2 1 1
PAIN MANAGEMENT 45 Headache Disorders Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine Schizophrenia
Yes
Yes Yes Yes Yes
2 1 2 1
48 49 50
51 Major Depressive Disorder Bipolar Disorder Yes No 1 NA
52
53 Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder SLEEP DISORDERS Disorders Associated with Intellectual Disabilities ENDOCRINOLOGIC DISORDERS Thyroid Disorders Adrenal Gland Disorders yes Yes Yes NO Yes NO Yes 3 1 1 NA 3 NA 3
54 55 56 57 58 59
60
Pituitary Gland Disorders 61 62 63 65 66 67 68 Erectile Dysfunction Benign Prostatic Hyperplasia Urinary Incontinence Menstruation-Related Disorders Hormone Therapy in Women Pregnancy and Lactation: Therapeutic Considerations Contraception
Yes NO NO
1 NA NA
Yes Yes
3 1
Yes Yes NO
2 1 NA
71
Osteoarthritis
Yes
74 Gout and Hyperuricemia 75 76 w3 w4 w5 Glaucoma Allergic Rhinitis Yes Yes yes no no 1 1 2 NA NA Yes 3
Medication Safety Evidence-Based Medicine Pharmacokinetics
w6 w7 w8 w9
Pharmacogenetics Pediatrics Geriatrics Palliative Care Solid Organ Transplantation
yes no no no
2 NA NA NA
70
yes
Hypovolemic Shock
14 35
Calcium and Phosphorus Homeostatis Venous Thromboembolism
yes yes
4 3
9 Hypertension
yes
3 7 8
Acute Coronary Syndromes Arrhythmias
yes yes yes
3 4 4
Names of algorithm figures
Agorithms sent to authors on
Comments from authors due on
NA
NA 1/29/2013 and revised algorithms sent on 6 Feb 30-Jan NA NA 1/29/2013 and revised sent on 8th Feb NA 30-Jan 29-Jan 30-Jan NA 30-Jan
NA
2.1 and 2.2 4.3, 4.5 ,4.6 ,4.7 and 4.8 na NA 21.2 and 21.3 NA 23.1, 23.2 and 23.3 24.3, 24.4 and 24.5 25.2, 25.3, 25.4 and 25.5 NA 28.1 and 28.3
13-Feb 5-Feb NA NA 5-Feb NA 6-Feb 5-Feb 6-Feb NA 6-Feb
29.1, 29.3, 29.4, 29.5 and 29.6 30.4 and 30.5 36.2 37.2, 37.3 and 37.4 41.1
29-Jan 30-Jan 30-Jan 29-Jan 30-Jan
5-Feb 6-Feb 6-Feb 5-Feb 6-Feb
42.1, 42.2 and 42.3
29-Jan
5-Feb
46.1
29-Jan
5-Feb
47.2 64.1 NA 84.3
29-Jan 30-Jan NA 30-Jan
5-Feb 6-Feb NA 6-Feb
85.1
29-Jan
5-Feb
NA NA
NA NA
NA NA
88.1 and 88.2 NA NA NA NA 94.1 and 94.2 NA 99.1
30-Jan NA NA NA NA 29-Jan NA 29-Jan
6-Feb NA NA NA NA 5-Feb NA 5-Feb
100.1 and 100.2 NA NA
30-Jan NA NA
6-Feb NA NA
13.2 NA 39.2 and 39.3 40.1 43.4
9-Apr-13 NA 9-Apr-13 9-Apr-13 9-Apr-13
16-Apr-13 NA 16-Apr-13 16-Apr-13 16-Apr-13
44.2 and 44.3
9-Apr-13
16-Apr-13
45.2 and 25.3 48.1 49.1 and 49.2 50.1
9-Apr-13 9-Apr-13 9-Apr-13 9-Apr-13
16-Apr-13 16-Apr-13 16-Apr-13 16-Apr-13
51.2 NA
9-Apr-13 NA
16-Apr-13 NA
53.1, 53.2 and 53.3 54.1 55.1 NA 57.7, 57.9A and 57.9B NA 59.3, 59.4 and 59.5
10-Apr-13 10-Apr-13 10-Apr-13 NA 10-Apr-13 NA 10-Apr-13
17-Apr-13 17-Apr-13 17-Apr-13 NA 17-Apr-13 NA 17-Apr-13
60.2 NA NA
10-Apr-13 NA NA
17-Apr-13 NA NA
63.2, 63.3 and 63.4 65.1
10-Apr-13 10-Apr-13
17-Apr-13 17-Apr-13
66.2 and 66.4 67.2 NA
10-Apr-13 10-Apr-13 NA
17-Apr-13 17-Apr-13 NA
71.4, 71.5, 71.6, 71.7 and 71.8
10-Apr-13
17-Apr-13
74.1, 74.5 and 74.6
10-Apr-13
17-Apr-13
75.5 76.2 w3-1 and w3-2 NA NA
10-Apr-13 20-Apr-13 24-Jun-13 24-Jun-13 24-Jun-13
17-Apr-13 27-Apr-13 28-Jun NA NA
W6-4 and W6-5 NA NA NA
24-Jun-13 24-Jun-13 24-Jun-13 24-Jun-13
28-Jun NA NA NA
70.2
25-Jun
2-Jul
14.1, 14.2, 14.4, 14.5 35.1-35.3
25-Jun 25-Jun
2-Jul 2-Jul
9.4-9.6
25-Jun
2-Jul
3.1-3.3 7.1-7.4 8.5, 8.6, 8.9, 8.12
25-Jun 28-Jun 25-Jun
2-Jul 4-Jul 2nd July
Comments received on
8-Mar 26-Feb
2/6/2013 and reply to query on Feb 7 2/6/2013 and 11th Feb updated changes received 30-Jan 7th feb 21-Feb
Jan 30/ Jan 30 5 Feb, 13 31-Jan 31-Jan 6-Mar
26-Feb
1/30/2013 and 5 Feb, 13
26-Feb 20-Feb 31-Jan
30-Jan
27-Feb
26-Feb 30-Jan
27-Feb
12-Apr 11-Apr-13 4/16/2013 and 18- Apr-13 11-Apr-13
23-Apr-13
16-Apr-13 23-Apr-13 17-Apr-13 10-Apr-13
24-Apr-13
12-Apr-13 17-Apr-13 18-Apr-13
7-May
16-Apr-13
11-Apr-13
11-Apr-13 13-Apr-13
12-Apr-13
17-Apr-13
17-Apr-13
23-Apr-13
24-Jun NA NA
24-Jun NA NA NA
25-Jun
26-Jun
26-Jun
27-Jun
28-Jun
Comments
PDF with color codes attached. Thanks. Cell algorithm colors are included on the attached figures.
My marked up algorithms are attached
I have attached Figure 29.6 with the colors indicated as requested. Figure 29.1 and 29.3 do not include recommendations so all boxes would be blue. / Yes, the box you refer to should also be green. Sorry for omitting that on the document I sent you. It should be green. am in receipt and will respond back in next couple of days...tx
On algorithm 47-02 the following color coding should occur per your guidelines: Top TWO Boxes - BLUE Left Sided FOUR Boxes starting with NON-Pharmacologic Treatment and the three below - RED Right Sided FIVE Boxes and the SINGLE box at the very bottom - GREEN. Attached are my suggested colors. They are in the sticky notes. Boxes without a sticky note should be blue. Top TWO Boxes - BLUE Left Sided FOUR Boxes starting with NON-Pharmacologic Treatment and the three below - RED Right Sided FIVE Boxes and the SINGLE box at the very bottom - GREEN. Here you go so sorry again for the delay! Our institution has greatly limited our Adobe PDF capabilities, so I had to use the Sticky Note feature. Hope that works. You can see the comments below I have looked over the algorithm & the examples. Our figure is actually one of the example pdfs that was sent (figure 116-01) and the colors for those cells will be the same for this figure.
Please find the attached figures with the desired colors marked. Again, sorry it took so long to get these back to you. We also found a couple of changes that needed to be made to the figures themselves, beyond the colors. I wasnt sure if this is the appropriate time to be making those sorts of changes, but they have been marked on the figure as well (i.e. one change on figure 88-02).
Here are the color coded charts for the UTI chapter. All the cells should be blue We also found a couple of changes that needed to be made to the figures themselves, beyond the colors. I wasnt sure if this is the appropriate time to be making those sorts of changes, but they have been marked on the figures as well (i.e. two changes on figure 100-02).
Attached is the algorithm with colors indicated by sticky notes. I hope thats ok. Here you go. We will have to add dimethyl fumerate to the text. Thank you, Attached is the color coded file./ Both boxes should be GREEN. Please see attached mark ups. Sorry these are now late. Not sure what happened (I sent them April 13th). Here are the recommended colors. They are indicated by sticky notes. And yes, we hope spring gets here before fall begins! Attached are the identified figures. Please also note that there was one error on 45-3, likely as a result of unclear instructions on my part within the text description. Thank you for correcting this also.
Attached you will find the color assignments for Fig 48-1. Attached you will find the figures along with the color assignments. Please feel free to contact me if you have any questions. Attached as requested. Please let me know if you have questions. SO sorry I misunderstood what you were asking!!! I add the color recommendations. The only question I had (and perhaps Christian can weigh in) is for the two boxes that being with the word maintain. I marked these as red because they are a recommendation for how long therapy should be administered but I didnt know if you meant that red should be used for more specific nonmedication treatment recommendations like psychotherapy.
Please find attached the algorithms with the colors marked for the cells for Figures 053-2 and 053-3. For Figure 053-1, the algorithm needs to have the same colors as the original IPAP GAD alorighm (same as 8th edition). The colors are keyed by level of evidence and IPAP wants us to keep the original algorithm intact. So, on that attachment, I instructed to color the cells as in the previous edition and as they originial published algorithm. Is this acceptable? Thank you! Attached is the one figure for Chapter 54 in the DiPiro book. Thanks and please let me know if you have any questions. Please see attached. Let me know if this is not sufficient and you need more information. Here are the algorithms. I have colored Figure 83-7 The other two I have outlined the boxes in color. Attached is a pdf indicating which colors should be assigned to the specific boxes. Please let me know if you have difficulty interpreting any of the writing.
I copied Dr. Jordan who is a co-author for this new edition. The figure is not complex, so I will just provide the information by e-mail. Please note a few other minor corrections. The boxed information in the figure is structured in six levels starting from the top (Level 1): Level 1, middle column: blue Level 2, left: red Level 2, right: green (change SRL to SA) Level 3, left: green (change SRL to SA) Level 3, middle column: red Level 3, right: green (change increase dose, frequency or combination to increase dose and/or frequency Level 4, middle column: red Level 5, left: red Level 5, right: green Level 6, middle column: red
Here are the 3 figures. I used the highlight function in tools to identify the boxes as red, green or blue per the desired color assignment noted below. Please holler if there are any other questions.
Please find the information you requested regarding coloration of 3 diagrams for my chapters on Benign Prostatic Hyperplasia and Erectile Dysfunction.
I have attached the color notations on the requested algorithms. Thanks. Cindy Ive attached color suggestions for the algorithms. I have formatting suggestions for the algorithms as well should I provide those comments now or will there be additional processing done before the final versions? am sorry this took so long. I have been traveling and having some problems with my email.
here is the mark-up on the PDFs
These are figures demonstrating the proteins and genes involved in eliciting drug response. So I dont think they qualify as treatment algorithms, with the particular colors indicated. If a color is needed, suggest blue for all since they are not recommendations.
I have attached the file for Figure 70.2 with the colors marked on the file. I have both written the colors and highlighted them with the corresponding color for each block. Anything that is not highlighted either green or red can be blue, per the color scheme of the book.
Attached are my figures with the colored cells as per your request. You may need to change the shades of the colors so they project well on the printed page, but my greens, reds, and blues should be obvious for this draft. Brian Sorry this includes all-
Figure 9.4 is not an algorithm. Please close up the spaces between any Roman numeral and a lower case 'a' (e.g. Xa instead of X a) throughout the figure. Choose whatever color you think would be appropriate for the shapes in this figure. Here is what the original figure had... Here is the color scheme for 9.5 as I was not able to make any modifications to the PDFs. Double check the call out box at the top of the figure--there seem to be some formatting issues (boxed 'x' rather than dashes) also same issue in the box at the bottom of the figure....(longterm has a boxed 'x' instead of a dash). Figure 9.5 is all drug therapy recommendations except for the top box which could be blue. All other boxes should be green Figure 9.6 is all drug therapy recommendations except for the top box which could be blue. All other boxes should be green
For figure 3.1, no recommendations are there, so no coloring is needed For figure 3.2 the bottom two boxes, one on the right one on the left are drug recommendations and should be GREEN For figure 3.3 the six boxes to the right of Standard Pharmacotherapy should be Green and the 4 boxes to the right of Add-On Pharmacotherapy should be GREEN I have indicated the colors for each of the cells for these figures using comment boxes directly on the PDF. Please let me know if you have any questions.
Remarks
Query regarding arts sent to author on 6th feb Query regarding arts sent to author on 6th feb
Note: there were no attachment thus queried with author
For the algorithm appearing in Fig. 14.04, in the box on bottom-right you have marked the text "Continue periodic assessment" as red and the text "infusions of LR as needed to maintain adequate perfusion" as green. Just wanted to let you know that we need to assign one color to a box. Since these both texts are appearing in one box, this box should be set either in Red or Green color. Please let us know which color should be used for this box. We have attached your marking of colors for this gorithm for your reference. Make it a green box.
Schedule for Dipiro-Batch1 (Chapters received until Jan 12) McGraw-Hill Production Manager: Catherine Project Developer: Brian Kearns Proofs Distribution: Contributors + Editors + MGH Arts Proof Distribution:- NA Compositor - Thomson XML: Yes Printer: CTPS Printer Date: 4 October, 13 Milestone Material to Thomson Original Scheduled dates 28-Dec-13 will be delivered Batch wise. For batch 138chapters recd. thus far , TD will deliver the cast off and quote by Jan 24. 21-Feb-13 25-Mar-13 3-Apr-13 15-Mar-13 2-Apr-13 9-Apr-13 23-Apr-13 27-May-13
Cast Off /Estimate to McGraw-Hill HE Thomson to send Sample Chapter to McGraw-Hill HE Copy Editing for Batch 1 inputs received until 12 Jan First Page proofs to Editors/contributors/Mcgraw-Hill for Batch 1 - 18 chapters (Chapters 1,2,4, 10, 19,21 to 24 , 25, 28-30, 36, 37, 41,42) First Page proofs to Editors/contributors/Mcgraw-Hill for Batch 2 - 19 chapters (Chapters 27, 46, 47, 64, 83-91, 93,94,96,99-101, 120 ) Return of First Page Proof corrections from Authors to Editors Return of First Page Proofs from Editor to TD Marked revised proofs to McGraw-Hill Editors will get 3 weeks for review of their chapters and contributors will get 1 week to review each chapter Schedule for Dipiro-Batch2 (Chapters received on 11 march 13) Milestone Material to Thomson Cast Off /Estimate to McGraw-Hill HE Thomson to send Sample Chapter to McGraw-Hill HE Copy Editing for Batch 2 inputs received on 11 March Thomson to send Printer Test
Original Scheduled dates 11-Mar-13 5-Apr-13 Already sent and approved 13-May-13 Already sent
First Page proofs to Editors/contributors/Mcgraw-Hill for Batch 1 - 15 chapters (Chapters 38, 39, 40, 43-45, 48-56) First Page proofs to Editors/contributors/Mcgraw-Hill for Batch 2 - 16 chapters (Chapters 13, 57 -63, 65-68, 71, 74-76) Return of First Page Proof corrections from Contributors to Editors Return of First Page Proofs from Editor to TD Marked revised proofs to McGraw-Hill Schedule for Dipiro-Batch3 (Chapters received on 9 April 13) Milestone Material to Thomson Cast Off /Estimate to McGraw-Hill HE Thomson to send Sample Chapter to McGraw-Hill HE Copy Editing for Batch 3 inputs received on 10 April (26 chapters) Thomson to send Printer Test First Page proofs to Editors/contributors/Mcgraw-Hill for Batch 1 - 13 chapters (Chapters 3, 5, 8, 9, 14, 17, 18, 31-35 and 70) First Page proofs to Editors/contributors/Mcgraw-Hill for Batch 2 - 13 chapters (Chapters 69, 80- 82, 92, 95, 97,98, 102-106) Return of First Page Proof corrections from Contributors to Editors Return of First Page Proofs from Editor to TD Marked revised proofs to McGraw-Hill Schedule for Dipiro-Batch4 (Chapters received on 22 May 13) Milestone
14-May-13 7-Jun-13 14-Jun-13 28-Jun-13 29-Jul-13
Original Scheduled dates 11-Mar-13 20-May-13 Already sent and approved 26-Jul-13 Already sent 10-Jul-13 9-Aug-13 16-Aug-13 30-Aug-13 6-Sep-13
Original Scheduled dates
Material to Thomson 22-May-13 Cast Off /Estimate to McGraw-Hill HE 20-May-13 Thomson to send Sample Chapter to McGraw-Hill HE Already sent and approved Copy Editing for Batch 3 inputs received on 10 April (26 chapters) 26-Jul-13 Thomson to send Printer Test Already sent First Page proofs to Editors/contributors/Mcgraw-Hill for 25 chapters (Chapters 6, 7, 12, 15, 16, 20, 26, 72, 73, 77, 79, 107 - 119 and 121)) 9-Aug-13 Return of First Page Proof corrections from Contributors to Editors 16-Aug-13 Return of First Page Proofs from Editor to TD 30-Aug-13 Marked revised proofs to McGraw-Hill 6-Sep-13
Actual Dates Application file for Design Awaited
23-Jan-13 21-Feb-13 25-Mar-13 26-Mar-13 15-Mar-13 2-Apr-13 16-Apr-13 29-Apr-13 27-May-13
Actual Dates 11-Mar-13 5-Apr-13
14-May-13
Actual Dates 11-Mar-13
and approved
Actual Dates 11-Mar-13
and approved
Sr no
Last Name Full name/ degree Hillis L. David Hillis, MD
Chapter # /
1 2 3 4 5
Lange Barletta Wilt MacLaughli n Saseen
Richard A. Lange, MD, MBA Jeffrey F. Barletta, Pharm.D., FCCM Jeffrey L. Wilt, M.D.. FACP, FCC{ Eric J. MacLaughlin, PharmD, FCCP, BCPS Joseph J. Saseen, PharmD
1 2 2 3
6
Nappi
7 8
Jean Nappi, BS, PharmD, FCCP, BCPS
4 5
Reed Rodgers
Brent N. Reed PharmD,BCPS

Jo E. Rodgers, PharmD, FCCP, BCPS
9
Talbert
10
deDenus
Robert L. Talbert, PharmD, FCCP, BCPS, FAHA Simon deDenus, B.Pharm, MSC, PhD Sarah A. Spinler, PharmD, FCCP, FAHA, BCPS
6 7
11
Spinler
12
Bauman
13
Jerry L. Bauman, PharmD, FCCP, FACC
Sanoski
Cynthia A. Sanoski, PharmD, BCPS, FCCP 8
14
Clark Nathan P. Clark, PharmD, BCPS 9
15
Witt Daniel M. Witt, PharmD, FCCP, BCPS,
18
Fagan
19 20 21
Hess Hersh
Susan C. Fagan, PharmD, BCPS, FCCP David C. Hess, MD
10 10 11
LAUREN R. HERSH,MD
Talbert Robert L. Talbert, PharmD, FCCP, BCPS, FAHA LtCol. Barbara J. Hoeben, PharmD, MSPharm, BCPS Robert L. Talbert, PharmD, FCCP, BCPS, FAHA Joseph F. Dasta, MSc, FCCM, FCCP 11 12 12 13
22
Hoeben
23
Talbert
24
Dasta
25
26 MacLaren
Rudis
Robert MacLaren, BSc, PharmD, FCCM, FCCP

Maria I. Rudis, PharmD, BScPharm Brian L. Erstad, Pharm.D., FCCM, FCCP, FASHP H. William Kelly, Pharm.D. 13 14 15
13
27
Erstad
28 29
Kelly
Sorkness
Christine A. Sorkness, PharmD 15
30
Bourdet
31 32 33 34
Sharya Vaughan Bourdet, PharmD, BCPS Dennis Williams, Pharm D. BCPS
16 16 17 17 17
Williams
Attridge
Levine Moote
Rebecca L. Attridge, PhrmD, MSc, BCPS

Deborah J. Levine, MD, FCCP Rebecca Moote, PharmD, MSc, BCPS
35
Vera Yolanda Y. Vera, PharmD Chanin Clark Wright, PharmD 18
36
Wright
18
37 38 39
Rao Williams
Satish SC Rao, MD, PhD, FRCP

Dianne B. Williams, PharmD Bryan Love, PharmD
19 19
Love
20
40 41 42 43
Thoma Tjp,a Hemstreet DiPiro Mathew N. Thoma, MD 20 20 21 22 Robert J. Ignoffo PharmD, FASHP, FCSHP Patricia H. Fabel, PharmD Virginia Flemming Patricia Powell Kacey Shealy 22 23 23 23 23
Matthew N. Thoma, MD
Brian A. Hemstreet, PharmD Cecily V. DiPiro, PharmD
44 45 46 47 48 49
Ignoffo Fabel Flemming Powell shealy
Sease
Julie M. Sease, PharmD, BCPS, BCACP Scott Bolesta, PharmD, BCPS
24
50
Bolesta 25
51 52 53 54 55 56
Halilovic Montgomery Deming Mangione Patel Dager Patricia A. Montgomery Paulina Deming, PharmD Robert A. Mangione, PharmD Priti N. Patel, PharmD, BCPS William E. Dager, PharmD, BCPS (AQ Cardiology) Jenana Halilovic, PharmD, BCPS, AAHIVP 25 26 27 27 28
28
57
Hudson Joanna Q. Hudson, PharmD, BCPS, FASN, FCCP 29
58
Wazny Lori d. Wazny, PharmD
59 60 61
Nolin Thomas D. Nolin, PharmD, PhD, FCCP, FCP Churchwell Mariann D. Churchwell, PharmD, BCPS Sowinski Kevin M. Sowinski, Pharm.D., FCCP
29 30 30
31
62 63
Lau Alan H. Lau, Pharm D, FCCP Mohamma Rima A. Mohammad, PharmD, BCPS d
32
33
64
Chessman Katherine H. Chessman, BS Pharm, PharmD
34
65
Matzke
66
Pai
67
Brophy
Gary R. Matzke, PharmD, FCP, FCCP, FASN, DPNAP Amy Barton Pai, PharmD, BCPS. FASN Donald F. Brophy,PharmD, MSc, FCCP, BCPS Jane Frumin, PharmD John W. Devlin, PharmD, FCCP, FCCM Gary R. Matzke, PharmD, FCP, FCCP, FASN, DPNAP
34 35 36 36 37 37 38 38 38
68
Frumin
69
Devlin
70
Matzke
71 72 73 74
Slattum Boling Hilli Peron
Peter Boling
Angela Hill
Emily P. Peron, PharmD, MS, BCPS, FASCP

Patricia W. Slattum, PharmD, PhD
38
75 76 77 78
Bainbridge Corboy Miravalle Jacquelyn L. Bainbridge, PharmD, FCCP 39 39 39
John Corboy Augusto Miravalle

Jose E. Cavazos
Cavazosdo not pay per rogers
40
79 80 81 82
Hovinga Phelps wheless
Collin A. Hovinga Stephanie J. Phelps, PharmD, BCPS James W. Wheless
41 41 41
Boucher
Bradley A. Boucher, PharmD, FCCP, FCCM G. Christopher Wood, PharmD, FCCP, BCPS Jack J. Chen, PharmD, BCPS, Merlin V. Nelson a David M. Swope, MD Jerry J. Baumann, PharmD, FCCP, FACC Chris M. Herndon Jennifer M. Strickland Deborah S. Minor, PharmD Marion Wofford, MD Julie A. Dopheide, PharmD, BCPP Stephen R. Pliszka, MD Valerie L. Ruehter, PharmD, BCPP Steven C. Stoner, PharmD, BCPP Paul L. Doering, MS
42 42 43 43 43 44 44 44 45 45 46 46 47 47 48
83 84 85 86 87 88 89 90 91 92 93 94 95 96 97
Robin Moorman Li Moorman Li 48 Paul L. Doering, MS Robin Moorman-Li, PharmD, BCACP Tami R. Argo Peter F. Buckley M. Lynn Crismon, PharmD 49 49 50 50 50 Wood Chen Nelson Swope Baumann Herndon Strickland Minor Wofford Dopheide Pliszka Ruehter Stoner Doering
97 98 99 100 101 102

Doering Moorman-Li Argo Buckley Crismon
103
KandoJudith C. Kando, PharmD, BCPP asked Teter

Teter Wells Drayton Christian J. Teter, PharmD, BCPP Barbara Wells Shannon J. Drayton, PharmD, BCPP 51 51 52
51
104 105 106
107
Pelic
Christine E. Pelic, MD
52
Cynthia K. Kirkwood, PharmD, BCPP Kirkwood 53
108
Sarah T. Melton, PharmD, BCPP, CGP Melton 53 Cynthia K. Kirkwood, PharmD, BCPP Kirkwood 54 Lisa B. Phipps Phipps 54 Barbara Wells 54
109 110 111

Wells
112 113 114
Dopp Phillips
John M. Dopp, PharmD Bradley G Phillips Nancy Brahm, PharmD, MS, BCPP, CGP
55 55
Brahm
56
115 116 117 118

Repas McKee Stewart alvarez Jerry R. McKee, PharmD, MS, BCPP Douglas Stewart, DO, MPH 56 56 57
Carlos A. Alvarez, Pharm.D., M.Sc., BCPS

Thomas Repas, DO, FACP FACOI FNLA FACE CDE
57
119
Triplitt Curtis Triplitt, PharmD, CDE 57
120
JonklassPayee check with her who to pay Talbert Jacqueline Jonklaas, MD, PhD 58
121 122
Robert L. Talbert, PharmD, FCCP, BCPS, FAHA
58
123
Dietrich
Eric Dietrich, PharmD
59
124
Gums
John G. Gums, PharmD, FCCP
59
125
Smith Calis- do not pay
Steven M. Smith PharmD, MPH

Karim Anton Calis, PharmD, MPH, FASHP, FCCP
59
60
126 127 128 129 130 131 132
Sheehan Yanovskido not pay O/Brien Ward Diaz Ragucci
Amy Heck Sheehan, PharmD Jack Yanovski, MD. PhD Barbara M. O'Brien Kristina E. Ward, BS, PharmD, BCPS Vanessa A. Diaz Kelly R. Ragucci, PharmD, FCCP, BCPS, CDE
60 60 61 61 62 62
133
Shrader
Sarah P. Shrader, PharmD, BCPS, CDE
62
Jacqueline Klootwyk
63
134
Elena M. Umland, PharmD Umland 63
135 136 137
Weinstein Pincus
Lara Carson Weinstein Kathryn Pincus, Deborah A. Sturpe, PharmD, BCPS, MA
63 64
Sturpe
64
138
Karim Anton Calis, PharmD, MPH, FASHP, FCCP
Calis
65
139
Devra Dang, PharmD, BCPS, CDE Dang 65 65 66 67
140 142 143 144

Kalantarido Sophia N. Kalantaridou u Mary Lee, PharmD, BCPS, FCCP Lee Mary Lee, PharmD, BCPS, FCCP Lee
145 Lam
ResmanTargoff
Sum Lam
Beth H. Resman-Targoff, PharmD, FCCP
68
69
146 147
Johnson Schonder
Heather J. Johnson, PharmD Kristine S. Schonder, PharmD
70
70
148 149 150 151 152
Buys Elliott Schuma Wahl
Lucinda M. Buys, PharmD, BCPS Elliott Schuma Kimberly R. Wahl, MD
71 71 72 72
Borchert Jill S. Borchert, PharmD, BCPS, FCCP 73
153
O'Connell Mary Beth O'Connell, PharmD, BCPS, FASHP, FCCP 73
154 155 156 157 158 159 160 161
Vandercek Clark Ernst Fravel Edward Fiscella Lesar May
Vandercek Clark Ernst Michelle A. Fravel, PharmD Deepak P. Edward, MD Richard G. Fiscella Timothy S. Lesar, PharmD Dianne May, PharmD, BCPS
73 74 74 74 75 75 75
76
162 163 164 165 166 167 168
Smith Sibald Gulliver Law Kwa Law Cook
Smith Sibald Gulliver Dr. Rebecca M. Law, PharmD Kwa Dr. Rebecca M. Law, PharmD Kristen M. Cook, PharmD, BCPS
76 77 78 78 79 79
80
169 170
Lyons Poon
William L. Lyons, MD Betsy Bickert Poon, PharmD
80
81
171
Pruemer
172 173
Witmer
Jane Pruemer, PharmD, BCOP, FASHP Char Witmer, MD
81 81
174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189
Chan, C.Y. Jennifer Frei-Jones Burgess Lee Hermsen Mitropoulos Rotschafer Blackford Glover, Reed Frei Frei Zhanel Hermsen Njoku Danziger
C.Y. Jennifer Chan, PharmD Melissa Frei-Jones, MD MSCI David S. Burgess, PharmD, FCCP Grace Lee Elizabeth Hermsen Isaac F. Mitropoulos, BS, PharmD John C. Rotschafer, PharmD, FCCP Martha G. Blackford, PharmD Mark L. Glover, Pharm D Michael D. Reed Christopher R. Frei, PharmD, MSc Bradi L. Frei,PharmD, MS George Zhanel Elizabeth Hermsen Jessica C. Njoku, PharmD, BCPS Larry K. Danziger Douglas N. Fish, PharmD
82 82 83 83 84 84 84 85 85 85 86 86 86 87 87 88
Fish
88
190 191 192 193 194 195
Pendland Crouch Odle Veverka Namdar Peloquin
Susan L. Pendland, Michael A. Crouch Brian L. Odle Angie Veverka, PharmD BCPS Rocsanna Namdar Charles A. Peloquin, PharmD
88 89 89 89 90 90
196 197 198 199 200 201

Jung Martin DiPiro Gross Olsen Rose Jung Steven J. Martin, PharmD joe dipiro Alan Gross Keith M. Olsen, PharmD 91 91 92 92 92
JV Anandan, PharmD
Anandan
93
202
Elizabeth A. Coyle, PharmD, FCCM, BCPS Coyle 94
203 204 205 206 207 208 209 210 211 212
Prince Knodel Armstrong Friedman Shehab Kang-Birken KilgoreSmith Brown Dresser Carver
Randall A. Prince Leroy C. Knodel, PharmD Edward P. Armstrong, PharmD Allan D. Friedman Ziad Shehab, MD S. Lena Kang-Birken, PharmD, FCCP Karla Kilgore-Smith Thomas E.R. Brown, PharmD Linda D. Dresser Peggy L. Carver, PharmD
94 95 96 96 96 97 97 98 98 99
213
Douglas N. Fish, PharmD
Fish
100
214 215 216

Kanji Hayney Salmaan Kanji, PharmD, BSc,Pharm, ACPR Mary S. Hayney, PharmD, MPH, FCCP, BCPS Peter L. Anderson, PharmD Anderson 103 101 102
217 218 219 220
Fletcher Kakuda Medina
Courtney V. Fletcher Thomas N. Kakuda, Patrick J. Medina, Pharm.D., BCOP
103 103 104
Shord
Stacy G. Shord, PharmD, BCOP, FCCP 104
221
Barnett
Chad M. Barnett, PharmD, BCOP

Francisco J. Esteva, MD, PhD Laura Boehnke Michaud, PharmD, BCOP, FASHP Val R. Adams, Pharm.D., FCCP, BCOP Deborah A. Frieze, PharmD, BCOP Lisa E. Davis, BS, PharmD, Patrick J. Medina, Pharm.D., BCOP Weijing Sun Jill M. Kolesar, PharmD, BCPS, FCCP
222 223 224
105 105 105 106 106 107 107 107 108
Esteva Michaud Adams
225 226 227 228 229
Frieze Davis Medina Sun Kolesar
230
Norris
231
Chan
232 233 234 235
Yee Smith Wolf Poon
Leann B. Norris, PharmD, BCPS, BCOP Alexandre Chan, PharmD, BCPS, BCOP Gary C. Yee, PharmD, FCCP Judith Smith, Pharm.D., BCOP, FCCP, FISOPP Judith K. Wolf, MD Betsy Bickert Poon, PharmD, FCCP
108 109 109 110 110
111
236
Seung Amy H. Seung, PharmD, FCCP, BCOP Chris Fausel, Pharm.D., BCPS, BCOP Patick Kiel, PharmD, BCPS, BCOP Timothy R. McGuire, PharmD, FCCP, BCOP Casey B. Williams, PharmD, BCOP
237
Fausel
111 112 112 113 113 114 114 115
238 239 240
Kiel McGuire Williams
241
McCullough Kristen B. McCullough, PharmD, BCPS
242
Merten
243
Simmons
Julianna Merten, PharmD, BCPS, BCOP
245
Ashley E. Simmons, PharmD
Walko
Christine M. Walko, PharmD, BCOP 115
246 248 249 250
O'Bryant Poust Liewer Perkins
Cindy L. O'Bryant, PharmD, BCOP Jamie C. Poust, PharmD, BCOP Susanne Liewer, PharmD, BCOP Janelle B. Perkins, PharmD, BCOP
116 116 117
117
251
Chessman
252
Kumpf
Katherine H. Chessman, BS Pharm, PharmD Vanessa J. Kumpf, PharmD, BCNSP Catherine M. Crill, PharmD, BCPS, BCNSP Todd W. Mattox, PharmD, BCNSP
118 118 119
253
Crill
254
Mattox
119
255
Kumpf Vanessa J. Kumpf, PharmD, BCNSP 120
256
Calis-do not Karim Anton Calis, PharmD, MPH, pay FASHP, FCCP 121
257
Chen, Judy Judy T. Chen, Pharm.D., BCPS, CDE
258 259 260 261 262 263 264
121 121 121 1W 1W W1 W10 W11 W12 W14 W14
Sheehan Yanovskido not pay Bazaldua Davidson Kripalani Chyka Terriff
Amy Heck Sheehan, PharmD Jack Yanovski, MD. PhD Oralia V. Bazaldua, Pharm.D., FCCP,BCPS DeWayne Davidson Sunil Kripalani, MD Peter A. Chyka, PharmD, FAACT, DPNAP, DABAT Colleen M. Terriff, PharmD, BCPS (AQID), AAHIVE Greene Shepherd,PharmD Stephanie M. Levine, MD Tamara Simpson Michelle S. Harkins, MD
268 270 271 272
Shepherd Levine Simpson Harkins
W15
273 274 275 276 277 278
Marshik Raissy Olsen allen Kirchain Dowling
Patricia L. Marshik, PharmD Hengameh H. Raissy, PharmD Keith M. Olsen, PharmD Rondall E. Allen William R. Kirchain, PharmD Thomas C. Dowling, PharmD, PhD, FCP
W15 W15 W16 W17 W17
W18
279 280 281 282

Alhusban Fagan Nichols
Ahmed Alhusban
Susan C. Fagan, PharmD, BCPS, FCCP Fenwick T Nichols, III, MD Timothy Dellenbaugh
w19 w19 w19
Dellenbaug h
w20
283 284 285
Munro Nelson
Stuart Munro Leigh Anne Nelson, PharmD, BCPP
w20 w20
Mark E. Schneiderhan, PharmD, Schneiderh BCPP an
w20
286
Amanda M Loya Loya W2
Sias
Jeri J. Sias, PharmD, MPH W2
290
Hall
291
Weimert
292
Sylvia
Philip D. Hall, PharmD, FCCP, BCPS, BCOP Nicole Weimert, PharmD, MSCR, BCPS Lynne M. Sylvia, Pharm.D.
W21 w21 W22
294 295 296 297 298 299 300 303 304
Law Law Rao
Dr. Rebecca M. Law, PharmD David T.S. Law Kamaksh V. Rao, PharmD, BCOP, CPP
W23 W23 W24 w25 w25 w25 W3 W3
Aeschliman Jeffrey R. Aeschlimann, n, Kerry L Laplante Laplante Rybak JOHNSON Weber Chiquette Michael J. Rybak, PharmD, MPH
SHAWN E. JOHNSON
Robert J. Weber Elaine Chiquette
W4
305
Bauer Larry Bauer W5
307 308 309 310
Cavallari Lam Nahata Taketomo
Larisa H. Cavallari, PharmD Y. W. Francis Lam, PharmD, FCCP Milap C/ Nahata Carol Taketomo
W6 W6 W7
W7
311 312
Gray
Shelly L. Gray, PharmD, MS
W8
Hajjar
313 314 315 316 317
Handler Hanlon Starner Astofi
Emily R. Hajjar, PharmD, BCPS, BCAP Steven M. Handler, MD, PhD Joseph T. Hanlon, PharmD, MS Catherine I. Starner, PharmD, BCPS, CGP Jill ASTOFI
W8 W8 W8 W8 W9
Chapter Title Cardiovascular Testing
Received yes
Email hillisd@uthscsa.edu
Cardiovascular Testing Cardiopulmonary Arrest Cardiopulmonary Arrest Hypertension Hypertension
yes yes yes yes yes
langera@uthscsa.edu
jbarle@midwestern.edu jeffwilt@me.com eric.maclaughlin@ttuhsc.edu Joseph.saseen@ucdenver.edu
Systolic and Distolic Heart Failure Acutely Decompensated Heart Failure Acutely Decompensated Heart Failure
yes yes yes
nappijm@musc.edu breed@unch.unc.edu jerodgers@unc.edu
Ischemic Heart Disease Acute Coronary Syndromes Acute Coronary Syndromes yes yes
talbert@uthscsa.edu
Simon.dedenus@icm-mhi.org s.spinle@usp.edu, s.spinle@usciences.edu
Arrhythmias
yes
jbauman@uic.edu
Arrhythmias
yes
cynthia.sanoski@jefferson.edu
Venous Thromboembolism
yes
nathan.clark@kp.org
Venous Thromboembolism
yes
dan.m.witt@kp.org
Stroke Stroke Geriatrics
yes yes
SFAGAN@gru.edu. DHESS@gru.edu Lauren.r.hersh@gmail.com'lauren.hersh @jefferson.edu talbert@uthscsa.edu
Hyperlipidermia Peripheral Arterial Disease Peripheral Arterial Disease Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock yes yes yes
emailhoeben@yahoo.com, barbara.hoeben@dm.af.mil talbert@uthscsa.edu
jdasta@mail.utexas.edu
Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock

Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock Hypovolemic Shock Asthma
yes
yes yes yes
rob.macLaren@ucdenver.edu rudis.maria@mayo.edu erstad@pharmacy.arizona.edu hwkelly@unm.edu
Asthma
yes
sorkness@wisc.edu
Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension
yes yes yes yes yes
sbourdet@gmail.com; sharya.bourdet@va.gov
dennis_williams@unc.edu beccalo@gmail.com levinedj@uthscsa.edu rmoote@regis.edu
Cystic Fibrosis Cystic Fibrosis
yes yes
yvera@swmail.sw.org, YVERA@sw.org, cwright@sw.org
gastroesophageal reflux disease gastroesophageal reflux disease
yes yes
SRAO@gru.edu.
DIMAY@gru.edu
loveb@sccp.sc.edu
Peptic ulcer disease
yes
Peptic ulcer disease Peptic ulcer disease Inflammatory bowel disease Nausea and vomiting Nausea and vomiting Diarrhea, Constipation and Irritable Bowel Syndrome Diarrhea, Constipation and Irritable Bowel Syndrome Diarrhea, Constipation and Irritable Bowel Syndrome Diarrhea, Constipation and Irritable Bowel Syndrome
yes yes yes yes yes yes yes yes yes
matthewthoma@msn.com:mathey.tho ma@va.org matthewthoma@msn.com brian.hemstreet@ucdenver.edu

southpole@comcast.net
robert.ignoffo@tu.edu
fabelp@sccp.sc.edu
powellp@sccp.sc.edu kmshealy@presby.edu
jmsease@presby.edu Portal hypertension and cirrhosis yes scott.bolesta@wilkes.edu Pancreatitis yes
Pancreatitis Viral hepatitis Celiac disease Celiac disease Acute Kidney Injury Acute Kidney Injury
yes yes
paulina.deming@gmail.com Mangionr@stjohns.edu patelp2@stjohns.edu

william.dager@ucdmc.ucdavis.edu jmaker@pacific.edu, halilovic@gmail.com
yes yes
Chronic Kidney Disease: Management of Complications
yes
jhudson@uthsc.edu
Chronic Kidney Disease: Management of Complications Hemodialysis and Peritoneal Dialysis Hemodialysis and Peritoneal Dialysis Drug-Induced Kidney Disease
yes yes yes yes
LWazny@exchange.hsc.mb.ca;lwazny@hsc.mb.ca Mariann.Churchwell@utoledo.edu ksowinsk@purdue.edu
nolin@pitt.edu
Glomerulonephritis Drug Therapy Individualization for Patients with Renal Insufficiency
yes yes
alanlau@uic.edu mohammadra@upmc.edu
Disorders of Sodium and Water Homeostasis
yes
chessmak@musc.edu
Disorders of Sodium and Water Homeostasis Calcium and Phosphorus Homeostatis Potassium and Magnesium Homeostasis
yes yes yes
gmatzke@vcu.edu
amy.bartonpai@acphs.edu
dbrophy@vcu.edu
Potassium and Magnesium Homeostasis Acid-Base Disorders Acid-Base Disorders Alzheimer's Disease Alzheimer's Disease Alzheimer's Disease
yes yes yes yes yes yes
jfrumin@gmail.com j.devlin@neu.edu
gmatzke@vcu.edu
pboling@mcvh-vcu.edu ahill2@health.usf.edu epperon@vcu.edu
pwslattu@vcu.edu Alzheimer's Disease yes
Multiple Sclerosis Multiple Sclerosis Multiple Sclerosis
yes yes yes
Jacci.Bainbridge@ucdenver.edu john.corboy@ucdenver.edu augusto.miravalle@ucdenver.edu cavazosj@uthsca.edu
Epilepsy
yes
Status Epilepticus Status Epilepticus Status Epilepticus
yes yes yes
sphelps@uthsc.edu
bboucher@uthsc.edu Acute Management of the Braiin Injury Patient Acute Management of the Braiin Injury Patient Parkinson's Disease Parkinson's Disease Parkinson's Disease Pain Management Pain Management Pain Management Headache Disorders Headache Disorders Childhood Disorders or ADHD Childhood Disorders or ADHD Eating Disorders Eating Disorders Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine Schizophrenia Schizophrenia Schizophrenia yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes cwood@uthsc.edu
jjchen@llu.edu dmswopemd@gmail.com tbaumann@mhc.net
DMinor@umc.edu mwofford@umc.edu dopheide@pharmacy.usc.edu pliszka@uthscsa.edu ruehtervl@umkc.edu StonerS@umkc.edu doering@cop.ufl.edu moorman@cop.ufl.edu
doering@cop.ufl.edu moorman@cop.ufl.edu
lynn.crismon@austin.utexas.edu
Depressive Disorders
yes
Judith.Kando@sunovion.com
Major Depressive Disorder Depressive Disorders Bipolar Disorder
yes yes yes
cteter@une.edu draytons@musc.edu
Bipolar Disorder
yes
peliccm@musc.edu
Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders
ckkirkwo@vcu.edu
yes
Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder Sleep Disorders Sleep Disorders
stmeltonpharmd@gmail.com
yes
ckkirkwo@vcu.edu
yes
yes
yes yes yes
jmdopp@pharmacy.wisc.edu bgp@uga.edu Nancy-Brahm@ouhsc.edu
Disorders Associated with Intellectual Disabillities
yes
Disorders Associated with Intellectual Disabillities Disorders Associated with Intellectual Disabillities Diabetes Mellitus Diabetes Mellitus
yes yes yes
jmckee@n3cn.org douglas-stewart@ouhsc.edu carlos.alvarez@ttuhsc.edu trepas@regionalhealth.com
yes
Diabetes Mellitus yes Thyroid Disease yes
curtis.triplitt@uhs-sa.com
jonklaaj@georgetown.edu
Thyroid Disease
yes
talbert@uthscsa.edu
Adrenal Gland Disorders
yes
ead1129@ufl.edu
Adrenal Gland Disorders
yes
jgums@ufl.edu
Adrenal Gland Disorders Pituitary Gland Disorders
yes
steven.smith@ucdenver.edu karim.calis@fda.hhs.gov
yes
Pituitary Gland Disorders Pituitary Gland Disorders Pregnancy and Lactation: Therapeutic Considerations Pregnancy and Lactation: Therapeutic Considerations Contraception Contraception
amheck@iupui.edu yanovskj@mail.nih.gov BMObrien@WIHRI.org kward@mail.uri.edu
raguccik@musc.edu
Contraception
yes
sshrader2@kumc.edu
jkloots88@gmail.com
Menstruation-Related Disorders
yes
elena.umland@jefferson.edu
Menstruation-Related Disorders yes
Menstruation-Related Disorders Endometriosis
yes yes
dsturpe@rx.umaryland.edu
Endometriosis
yes
KCalis@mail.nih.gov
Hormone Therapy in Women
yes
ddang@stfranciscare.org
Hormone Therapy in Women Hormone Therapy in Women Erectile Dysfunction Benign Prostatic Hyperplasia yes yes yes yes SophiaKalantaridou <sophiakalantaridou@gmail.com>
MLEEXX@midwestern.edu MLEEXX@midwestern.edu
Urinary Incontinence
Systemic Lupus Erythematosus and Other Collagen-Vascular Disorders
yes
yes
lams1@stjohns.edu
beth-resman-targoff@ouhsc.edu
Solid Organ Transplantation Solid Organ Transplantation
yes yes
johnsonhj@upmc.edu schonderks@upmc.edu
osteoarthritis osteoarthritis Rheumatoid Arthritis Rheumatoid Arthritis
yes yes yes yes
c.buys@slmef.org arthur.schuna@va.gov Kimberly.wahl@va.gov
Osterprosis
yes jborchert@midwestern.edu
Osterprosis
yes
ao4856@wayne.edu
Osterprosis Gout and hyperuricemia Gout and hyperuricemia Gout and hyperuricemia Glaucoma Glaucoma Glaucoma Allergic Rhinitis yes yes yes yes yes yes yes
michael-ernst@uiowa.edu michelle-fravel@uiowa.edu Deepak.edward@gmail.com fisc@uic.edu LesarT@mail.amc.edu
yes
JMAY@gru.edu
Allergic Rhinitis Acne Vulgaris Psoriasis Psoriasis Atopic Dermaitis Atopic Dermaitis Anemias yes yes
debra.sibbald@utoronto.ca
drgulliver@newlabresearch.com rlaw@mun.ca
yes yes yes
rlaw@mun.ca (use as contact for Kwa)

rlaw@mun.ca kmcook@unmc.edu
Anemias Coagulation Disorders
yes yes
wlyons@unmc.edu betsy.poon@flhosp.org
Coagulation Disorders Coagulation Disorders
yes yes
jane.pruemer@UC.edu witmer@email.chop.edu
Sickle cell anemia Sickle cell anemia Antimicrobial Regimen Selection Antimicrobial Regimen Selection Central Nervous System Infection Central Nervous System Infection Central Nervous System Infection Lower Respiratory Tract Infection Lower Respiratory Tract Infection Lower Respiratory Tract Infection Upper Respiratory Tract Infections Upper Respiratory Tract Infections Upper Respiratory Tract Infections Influenza Influenza Skin and Soft Tissue Infections
yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes
jennifer.chan@mhshealth.com; chanj@uthscsa.edu freijones@uthscsa.edu
burgessd@uthscsa.edu leeg3@uthscsa.edu;glee23@gmail.com syka82@yahoo.com findissac@hotmail.com Rotsc001@tc.umn.edu mblackford@chmca.org mglover@nova.edu mreed@chmca.org freic@uthscsa.edu frei@uiwtx.edu syka82@yahoo.com
Syka82@yahoo.com
Skin and Soft Tissue Infections
yes Skin and Soft Tissue Infections Infective Endocarditis Infective Endocarditis Infective Endocarditis Tuberculosis Tuberculosis Gastrointestinal Infectionsand Enterotoxigenic Poisonings Gastrointestinal Infectionsand Enterotoxigenic Poisonings Intra-abdominal infections Intra-abdominal infections Intra-abdominal infections yes yes yes yes yes yes yes yes yes yes
doug.fish@ucdenver.edu
crouchm@mail.etsu.edu odle@mail.etsu.edu angie.veverka@carolinashealthcare.org Rocsanna.Namdar@ucdenver.edu Peloquin@cop.ufl.edu
steven.martin@utoledo.edu
alan.edward.gross@gmail.com kolsen@unmc.edu
Jvanandan38@yahoo.com
Parasitic diseases
yes
ecoyle@uh.edu
Urinary Tract Infections yes
Urinary Tract Infections Sexually Transmitted Diseases Bone and Joint Infections Bone and Joint Infections Bone and Joint Infections Sever Sepsis and Septic Shock Sever Sepsis and Septic Shock Superficial Fungal Infections Superficial Fungal Infections Invasive Fungal Infections
rprince@uh.edu knodel@uthscsa.edu armstrong@pharmacy.arizona.edu
zshehab@peds.arizona.edu lbirken@pacific.edu
tom.brown@utoronto.ca
peg@umich.edu
yes
Infections in Immunocompromised Patients
yes
Antimicrobial Prophylaxis Vaccines and Other Immunobiologics
yes yes
doug.fish@ucdenver.edu skanji@ottawahospital.on.ca;skanji@to h.on.ca mshayney@pharmacy.wisc.edu
Human Immunodeficiency Virus Infection yes peter.anderson@ucdenver.edu Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Infection Cancer Treatment and Chemotherapy yes yes yes patrick-medina@ouhsc.edu
Cancer Treatment and Chemotherapy
yes
stacy.shord@fda.hhs.gov
Breast Cancer Breast Cancer Breast Cancer Lung Cancer Lung Cancer Colorectal Cancer Colorectal Cancer Colorectal Cancer Prostate Cancer
cmbarnet@mdanderson.org fjesteva@mdanderson.org lboehnke@mdanderson.org vadam0@email.uky.edu frieze@u.washington.edu
l.davis@usp.edu patrick-medina@ouhsc.edu sunw@upmc.edu jmkolesar@pharmacy.wisc.edu
Prostate Cancer Lymphomas Lymphomas Ovarian Cancer Ovarian Cancer Acute Leukemias
norris@sccp.sc.edu phaac@nus.edu.sg gcyee@unmc.edu jasmith@mdanderson.org jwolf@mdanderson.org betsy.poon@flhosp.org
Acute Leukemias Chronic Leukemias Chronic Leukemias Multiple Myeloma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic Syndromes Renal Cell Carcinoma
yes yes yes yes yes yes yes yes
aseung1@jhmi.edu cfausel@iuhealth.org pkiel@clarian.org trmcguir@unmc.edu casey.williams@sanfordhealth.org McCullough.Kristen@mayo.edu Merten.Julianna@mayo.edu aesimmon@email.unc.edu;ashleysimmons@unc.edu
Renal Cell Carcinoma
yes
cwalko@email.unc.edu
Melanoma Melanoma Hematopoietic Cell Transplantation Hematopoietic Cell Transplantation
yes yes yes yes
cindy.obryant@ucdenver.edu Jamie.Poust@uch.edu sliewer@nebraskamed.com jperkin1@health.usf.edu
Assessment of Nutrition Status, and Nutrition Requirements Assessment of Nutrition Status, and Nutrition Requirements Parenteral Nutrition Parenteral Nutrition
yes yes yes yes
chessmak@musc.edu vanessa.kumpf@vanderbilt.edu ccrill@uthsc.edu todd.mattox@moffitt.org
Enternal Nutrition
yes
vanessa.kumpf@vanderbilt.edu
Obesity
yes
karim.calis@fda.hhs.gov, kcalis@mail.nih.gov
Obesity Obesity Obesity Health Literacy Health Literacy Health Literacy Clinical Toxicology Emergency Prepardeness Chemical and Radiological Terrorism Pulmonary Function Testing Pulmonary Function Testing Drug-Induced Pulmonary Disease
yes yes yes
jtchen@purdue.edu amheck@iupui.edu yanovskj@mail.nih.gov

bazaldua@uthscsa.edu davisond3@uthsca.edu sunil.kripalani@Vanderbilt.edu pchyka@utmem.edu terrifc@empirehealth.org greene_shepherd@unc.edu levines@uthscsa.edu peters@uthscsa.edu; MHARKINS@SALUD.UNM.EDU
Drug-Induced Pulmonary Disease Drug-Induced Pulmonary Disease Evaluation of the Gastrointestinal Tract Drug-induced liver disease Drug-induced liver disease Quantification of Renal Function
pmarshit@salud.unm.edu hheidarian-raissy@salud.unm.edu kolsen@unmc.edu wkirchai@xula.edu tdowling@rx.umaryland.edu
Evaluation of Neurologic Illness Evaluation of Neurologic Illness Evaluation of Neurologic Illness
aalhusban@georgiahealth.edu sfagan@georgiahealth.edu fnichols@georgiahealth.edu Timothy.dellenbaugh@dmh.mo.gov
Evaluation of Psychiatric Illness
Evaluation of Psychiatric Illness Evaluation of Psychiatric Illness nelsonla@umkc.edu
meschnei@d.umn.edu Evaluation of Psychiatric Illness
Cultural Competency
amloya1@utep.edu
Cultural Competency
jjsias@utep.edu
Function and Evaluation of the Immune System Function and Evaluation of the Immune System Allergic and Pseudoallergic Drug Reactions
hallpd@musc.edu weimert@musc.edu lsylvia1@tuftsmedicalcenter.org
Dermatologic Drug Reactions Dermatologic Drug Reactions Drug-Induced Hematologic Disorders Laboratory tests to direct antimicrobial pharmacotherapy Laboratory tests to direct antimicrobial pharmacotherapy Laboratory tests to direct antimicrobial pharmacotherapy Medication Safety Medication Safety Evidence-Based Medicine
rlaw@mun.ca d.law@utoronto.ca kvrao@unch.unc.edu
m.rybak@wayne.edu
Shawn.Johnson@osumc.edu Robert.Weber@osumc.edu
elainechiquette@gmail.com
Clinical Pharmacokinetics
Pharmacogenetics Pharmacogenetics Pediatrics Pediatrics
labauer@u.washington.edu humma@uic.edu
lamf@uthscsa.edu
nahata.1@osu.edu
ctaketomo@chla.usc.edu
Geriatrics
slgray@u.washington.edu
Geriatrics
emily.hajjar@jefferson.edu
Geriatrics Geriatrics Geriatrics Palliative Care handler@pitt.edu jth14@pitt.edu CStarner@primetherapeutics.com;;cstar ner99@gmail.com
JAstolfi@excelleRx.com
Schedule Shared on
Comments received
21-Jan-13 21-Jan-13 23-Jan-13 23-Jan-13 25-Apr-13
That time frame does not fit in with our schedule. Please suggest an earlier or later time frame/ The following week (Mar 9-16th) looks good.
Can you please use my correct email? I have not had the @uchsc.edu email in 6 years. I have provided my correct email many times prior and this was a problem for the last editon. My email is Joseph.saseen@ucdenver.edu Also, I will be on vacation the first 2 weeks of July so I anticipate not being able to comply with your 7 day turn around. Please send eproofs./ Please also send them to Robbie Parker rparker@uthsc.edu
25-Apr-13 29-Jan-13 25-Apr-13
25-Apr-13
Brent and I have discussed and we would both like to review via eproofing. Personally, I depart for a family vacation on 7/13-7/18 and then transition into a professional meeting from 7/18-7/21. Can we either get the e-proof prior to 7/10 (perhaps in mid-late June) OR can we get an extension on the deadline to 7/26? Kind regards.
1-Jun-13
1-Jun-13 25-Apr-13
We prefer eProofs. Dr. de Denus is on vacation at that time. Would it be possible for us to receive the proofs either /before July 31 or after August 26th? Sarah/ OK thanks
You can send the page proofs to my home address: 2404 Doral Dr. Blackwood, NJ 08012 E proofing is fine. I will be working in July (no vacation) Saloni, Edith Nutescu and Stuart Haines are no longer authors on this chapter and should be removed from all future correspondence. I prefer E-proofing. I have no vacation conflicts currently. Will let you know if that changes. Thanks, 25-Apr-13 23-Jan-13 23-Jan-13 Dan eProof will be fine with me. Timing is fine
25-Apr-13
25-Apr-13
1-Jun-13 1-Jun-13 30-Mar-13
30-Mar-13 30-Mar-13 25-Apr-13 1-Jun-13
Thanks for the advance notice. Either mode is fine with me so please choose the mode that is easiest for you. Please note that I will be out of town the end of June through about July 10th so if for some reason the proof is delayed I will not get to it until I am back.
E-proofing will work for me. I would prefer E-proofing
1-Jun-13 1-Jun-13 1-Jun-13 25-Apr-13 25-Apr-13
Plan confirmed. I prefer to receive the proofs as hard copy, but defer to Bill as to his preference. Chris I would prefer to receive the proofs electronically. I dont have plans for vacation during this time in August.
We would like it electronically. No July vacation scheduled yet, so should be able to meet the deadline. 25-Apr-13 25-Apr-13 I believe Dr. Vera and I will use the E-proof method if you will include instructions on how to do so. We should be available the week of July 10th. 25-Apr-13 29-Jan-13 29-Jan-13 Prefer electronic. I would prefer E-Proofing. I have no vacation plans during that time period. I do not have any vacation plans during late July/early August, so that should work out fine for me. One of the emails for my coauthor was incorrect, so I've updated that with this email. I've not had a chance to talk with him about his schedule. I'm looking forward to seeing the proof of our chapter. 31-May-13 31-May-13 31-May-13 23-Jan-13 I will review the proofs using the E-proofing method. You can send the link to me; only one of us needs to review the proofs.
23-Jan-13 23-Jan-13 29-Jan-13
29-Jan-13 29-Jan-13
I would prefer the online method. I prefer online.
23-Jan-13
29-Jan-13
Hi Saloni. E-proofs will be fine for me. I dont foresee any problems with my being able to comply with the dates you have given me. Thanks so much! Julie I look forward to working with you and should have no problem meeting the deadlines set forth. I would prefer to receive the galleys electronically. Please let me know if there is anything else you need from me.
31-May-13 2-Feb-13 2-Feb-13 23-Jan-13 We are most happy to utilize the E-Proofing process. We have no vacation plans during the period of April 2-9.
23-Jan-13
We would prefer e-proofing. Also, no vacation plans between now and March for me. Dr Wazny and I would prefer to use the e-proofing method. I would also like to request that since she and I will be coordinating our proofreading efforts that we have until early the following week to complete the review (March 26 if possible). We do not anticipate being out during the time the proofs are to be made available. Let us know if you need any additional information. E Proofing would be preferred. Eproofing is fine Thank you for your email. I prefer to receive proofs via email (EProofing). The schedule outlined below fits well into my vacation plans. I will out of the office from June 30-July 7, and again from July 26-August 5.
23-Jan-13 23-Jan-13 29-Jan-13 29-Jan-13
25-Apr-13 25-Apr-13
25-Apr-13
I would like the online method (e-proofing). As for time scheduled off, I plan on being off from June 22nd to the 30th.
25-Apr-13 25-Apr-13 25-Apr-13
Thanks for the email. As it turns out, I am on vacation at a family wedding in San Francisco beginning Wed, July 10 and ending Monday, July 15, which is exactly the time frame mentioned for my proof review. However, I wouldn't mind getting the chapter before I leave because I will likely have some time on the plane flights to review it; however, I can't guarantee that I would get it back by the 17th. If I could get it on the 10th electronically but have until the 22nd to return it, that would work best with my vacation plans. Thanks.
29-Jan-13 29-Jan-13 23-Jan-13 NA 28-Mar-13 28-Mar-13 28-Mar-13
In regards to vacation plans, I don't currently have anything scheduled for March, so a quick turn-around to Dr. Matzke should be no problem.
Hi Saloni: I will opt for the e proofing option and I will be around during this March period NA
That schedule should work for me. I will be out of the office from tomorrow through April 8, June 24-28, and July 15-19. 28-Mar-13 30-Mar-13 30-Mar-13 30-Mar-13 My vacation plans during this time are the following: I will be in Key West, FL from 5/10 thru 5/14/2013 On April 3: Thank you. I will let you know if I need 1-2 extra days once I see the comments/changes. Susan Rogers I would prefer to receive the proofs electronically.
30-Mar-13
29-Jan-13
28-Jan-13 28-Jan-13 30-Mar-13 30-Mar-13 30-Mar-13
Thanks for letting me know about the chapter review process and timetable. March 15 should work out fine for me to review the chapter.
30-Mar-13 30-Mar-13 28-Jan-13 28-Jan-13 28-Jan-13 28-Jan-13 30-Mar-13
This schedule is fine. Thank you for your help.
I will be available,thanks
30-Mar-13 30-Mar-13
This timetable works fine for me.
30-Mar-13 Nice to meet you electronically. I will be out of the country on vacation from May 2 to May 16. On May 17, I fly out for a relatively intense meeting that lasts until the 21. I would ask that if possible the time line be pushed back a week dependent on Christian's schedule.
30-Mar-13 30-Mar-13
30-Mar-13 Thanks for the information. I will not be on vacation during the week of the 14-21. I will likely be covering our consult service myself on the 16th and 17th during our resident retreat. If there is any chance the document is ready by the 13th, I may have some time in the afternoon to start reviewing.
30-Mar-13
30-Mar-13
30-Mar-13 30-Mar-13 Thank you so much for letting me know!
30-Mar-13 30-Mar-13 Dear Saloni: Thank you for letting me know the schedule. I have had a change in plans and will be out of the office during this period. Would it be possible for the galley link to be available the first of the month (May)? Please let me know an alternate date. As far as I can determine, I will be available at the times outlined below. Thanks for moving this along. I do not have any plans for leave from May 14th through 21st. Thanks
30-Mar-13 30-Mar-13 30-Mar-13 28-Mar-13
28-Mar-13
I am going to let Todd email you about our preference for the chapter proof, if he hasn't already done so. But I just wanted to send you my possible vacation plans. I MAY be out of town the week of August 5th, but should be in town the following week, so I don't foresee any problems with meeting the proofing deadline if the dates you listed below do not change. I think it would be easier for all authors for Diabetes Mellitus to give us access to E-Proofing. Curtis Triplitt E proofs would be good. Please change the email contact you are using. It is not one I usually use. The correct one is below.Thank you.Jacqueline Jonklaas Associate Professor jonklaaj@georgetown.edu PLEASE NOTE NEW EMAIL ADDRESS
28-Mar-13
29-Mar-13
29-Mar-13 29-Mar-13
We would prefer the e-proofing option. However, we all have travel plans during the month of June. If possible, we would request to receive the proof in early or mid-May to allow time for review and re-submission; we are not sure how much time we will have to devote during our time away in June.
29-Mar-13
30-Mar-13 30-Mar-13 30-Mar-13 30-Mar-13 30-Mar-13
Please send the electronic version of the galleys to ALL study coauthors (four individuals). Two hard-copy proofs should be sentone to me at the Silver Spring address and one to co-author, Dr. Joe Jordan (see below).
30-Mar-13 Hi there. Please note my email has changed it is sshrader2@kumc.edu. We also are at a meeting during the time frame you proposed. Can we move the due date back by at least a week? Thank you. Sarah Shrader
41363
I am changing jobs this summer and my personal email address is jkloots88@gmail.com if you need to get a hold of me. Also, my new job will be at Duquesne University School of Pharmacy starting July 1, but do not have an email address yet.
30-Mar-13
If I receive them on the 7th, that is fine Ill block out time on the 9th and 10th. I will be away from the office with limited time to work on these from June 4-8 and June 11-15.
29-Jan-13
Hello I am on vacation March 29-April 7, and therefore will need a different schedule
30-Mar-13
30-Mar-13
30-Mar-13
30-Mar-13
I might be out of country in June. Is it possible to postpone it to after July 4th?
I will be on vacation from August 3 through August 21. Please adjust the schedule for review of my chapter proofs accordingly. 25-Apr-13 25-Apr-13 The E-proofs are fine to send to me to review online. I also want to let you know that I will be on vacation from 6th July until 15th July 2013. If it is possible to extend the deadline to review the proofs until the week of 22nd July, that would be preferred for me.
25-Apr-13 30-Mar-13 31-May-13 31-May-13
Thank you. Ill mark these dates in my calendar. Have a good weekend, 31-May-13 Great news. There have been a couple major changes so we will try to minimize the changes but might need to add an addendum. Can we get the chapter a week earlier or later? I am on vacation from 8/7 to 8/18. Since I will be traveling with frail parents and kids, won't be much time to proof a chapter. Mary Beth
31-May-13
30-Mar 30-Mar 30-Mar-13 30-Mar-13 30-Mar-13
The timeline is good for me.
18-Apr-13 31-May-13
The health system changed names for the second time in the last few years. Sorry for the confusion. Send the page proofs and I will turn them around quickly. Thanks. Michael
31-May-13 31-May-13
25-Apr-13 25-Apr-13
I would just like to request they be sent as soon as possible. We are in the middle of an international adoption and are anticipating travel some time in August or September and will be out of the country for 2 weeks. I just want to make sure it doesn't end up the week you send the proofs. Thanks!
25-Apr-13 25-Apr-13 25-Apr-13
I am going to be out of town without computer/email access August 12-19. Is there any way I can get this a little sooner so that I can meet this deadline?
25-Apr-13 25-Apr-13 23-Jan-13 23-Jan-13 29-Jan-13 29-Jan-13 29-Jan-13 23-Jan-13 23-Jan-13 23-Jan-13 29-Jan-13 29-Jan-13 29-Jan-13 29-Jan-13 I would like to receive the proofs via E-proofing. Thanks! The schedule is acceptable, thanks! Please forward me the proofs as an E-Proofing account. Thanks. M, The schedule is fine with me as well E-proofs will work great.
E-proofing please. Thanks
29-Jan-13
I would prefer to get chapter proofs (both chapters 88 and 100) via Eproofing so that my co-authors would also have access to the proofs. I also wanted to let you know that I will be out of town from March 30th through April 7th, so it will be very difficult to get proofs returned within one week if they are sent during that time. Thanks, I would lean towards e-proofing, but Angie I leave the decision to you as lead author. AOK with me. E-proofing is the preferred method for this chapter. I have no vacation plans that would interfere with the schedule.
23-Jan-13 23-Jan-13 23-Jan-13
29-Jan-13
e proofs are preferred There will be 3 of us working from different locations. At the moment, I do not have vacation plans in April.
29-Jan-13 25-Apr-13 25-Apr-13
23-Jan-13
Thank you for your note announcing the review of Pharmacotherapy and requesting our preference for review. I will happy to go with the electronic version (E-Proofing) for the review. In terms of vacation, I not not plan to take any vacation between now and April, 2013. I will complete the review as requested and meet the deadline set. Thank you. Kind Regards. I am currently out of the office with limited access to email and will return Wednesday January 23, 2013. If you need immediate assistance, please contact Gerida Brown at 713-743-3260.
23-Jan-13 23-Jan-13 25-Apr-13 29-Jan-13 29-Jan-13 25-Apr-13 25-Apr-13 25-Apr-13 25-Apr-13
We would prefer to receive our proofs electronically. You have the correct email addresses for Dr. Shehab and myself.
23-Jan-13
I will be out of the country with limited email access april 5-15. I would prefer an e version for proofing I would prefer to get chapter proofs (both chapters 88 and 100) via Eproofing so that my co-authors would also have access to the proofs. I also wanted to let you know that I will be out of town from March 30th through April 7th, so it will be very difficult to get proofs returned within one week if they are sent during that time. Thanks, Electronic for me please. No vacation plans as of yet for that time frame. I have no plans to be out of town between August 9 and August 16. I should be able to meet this deadline. Saloni, thanks for the heads up. I will be taking a vacation near that time, although the final dates are not firm. Can these dates be flexible? Thanks
29-Jan-13 23-Jan-13 25-Apr-13
25-Apr-13 25-Apr-13 25-Apr-13 25-Apr-13
25-Apr-13 25-Apr-13 25-Apr-13 25-Apr-13 25-Apr-13 25-Apr-13 31-May-13 31-May-13 31-May-13
I will befor returning from vacation on August 9, 2013. Thanks your e-mail and for helping with the chapter. I will be out of the country from June 7th to June 17th. Any other time should be fine for me.
31-May-13 31-May-13 31-May-13 31-May-13 31-May-13 31-May-13
I am not on vacation that week of august, however, if things are behind schedule, I will be gone the first week of septmeber. jk I will not be on vacation that week.
Thank you this timeline will work!
31-May-13 31-May-13 31-May-13 31-May-13 31-May-13 31-May-13 31-May-13 31-May-13 1-Jun-13
I will be on vacation August 10-19, so if there is another time frame for this it would be much appreciated.
Thanks Saloni. I will be on vacation the first week of August, but should be able to complete the review on time. Thanks, Casey No vacation plans here.
Neither are authors on the chapter any more. I do not have updated emails. Ninh M. La-Beck: irenela@unc.edu Mark D. Walsh: walshmd@email.unc.edu 1-Jun-13 1-Jun-13 1-Jun-13 1-Jun-13 Thank you for your email. I have changed positions and have a new email: jperkin1@health.usf.edu<mailto:jperkin1@health.usf.edu>. Please make a note of this for future communications.
1-Jun-13 1-Jun-13 1-Jun-13 1-Jun-13
I am going to let Todd email you about our preference for the chapter proof, if he hasn't already done so. But I just wanted to send
I apologize for not responding sooner. Unfortunately I didnt get to your message before leaving town for several days.
Regarding the method for reviewing proofs, E-proofing would be ideal, especially from an efficiency standpoint. If I understand correctly, any changes would be made directly to the online copy. But can the online proof be printed for preliminary review without internet access? If so, then we would prefer the e-proofing method. If not, then we would prefer the hard copy method.
Also, the timeline for review in August should work for me as well. The only other time I have planned for being out of town is 7/11-22.
Please get back with me if you have any questions. 1-Jun-13 My preferred mode of receiving the proofs is e-proofing. I have no scheduled vacation plans for the time frame noted below.
29-Jan-13
1-Jun-13 1-Jun-13 1-Jun-13 1-Jun-13
Thanks Jack. Saloni, the proposed delivery date is fine with me. With regards to the proofs, as we've done with my other two chapters, please send both the e-proofs and hard copy proofs.
The time line is fine for me. E-proofs are best for me.
1-Jul 1-Jul
E-proofing is fine with me. I will be on vacation July 17-30 but will have access to the computer for this. Michelle 18-Jun 18-Jun 18-Jun
We would like to have the E-proofing please.
Hello Saloni I would prefer the E-Proofs, thanks, Tom
I will be available to review during that week. Can you please change the email address for one of the authors listed below. It is incorrect: Timothy.dellenbaugh@dmh.mo.gov Thanks LAN
wn starting July 27th and returning August 5th. Not sure what the edits will look like but, so I was wondering if I could get the draft soon
1-Jul
Thanks for your e-mail. I am returning out of town from vacation on July 24. I do have another
Thank you for the advance notice. I will be on vacation in August so there should be no issue with this deadline.
25-Jun
Thank you for the email. I am available, and have no vacation plans the week of July 24-31, so
Dear Saloni I am the only author (along with a co-author) for this revised chapter so please o for future communication, please use elainechiquette@gmail.com. Thank you. elaine
Thank you for your note. I thought that I would share my summer schedule with you, too. I should be able to get these proofs back to you by the middle of August. Regards, Larry
I will be out of town July 4th returning July 8th. 18-Jun
TD's Response
schedule is changed as per Editor's confirmation (March 9 - 16) Author's email address has been updated on March 5
We received this email address in the contact list which we received in the inputs. Going forward we will send our future correspondence at Joseph.saseen@ucdenver.edu. Sorry for the inconvenience. Thanks for letting us know that you are not available during the first two weeks July. Please let us know if it is fine with you to send comments/corrections of your chapter by 23th July instead of 17th July. This will work for me. Thank you.
Thanks for confirming the mode of receipt of page proofs. Also, thanks for letting us know that Dr. de Denus is not available during the time line we proposed below, so we will send you page proofs of your chapter by 23rd July and you need to return your corrections/comments by 30th July to Dr. Talbert. I hope it is fine with you now. OK thanks
Thanks for sending your home address. We will be shipping hard copy of page proofs of your chapter to this address.
Email ID has been changed, id mentioned is the updated one Email ID has been changed, id mentioned is the updated one
Thanks for letting us know about your plans. We will send you e-proofs as it is the most convenient and fast mode of transferring files. Shipping hard copy proofs takes time. Since you are away end of June through about July 10th, we will be sending the Page proofs of your chapter to you on 7th June and you can return your comments/corrections to Dr. Talbert by 14th June . Please do let me know incase of any concern with this change of dates .
Hard Copy to be sent
Email ID has been changed, id mentioned is the updated one Email ID has been changed, id mentioned is the updated one
schedule is changed as per Editor's confirmation now, editor will receive comments by March 26
Thanks for confirming that e-proofing is fine with you and sharing your plans with us. Since the page proofs of your chapter will be sent to you on 10th July, we understand the below-mentioned schedule is fine with you.
Thanks for sharing your vacation plans with us. We will send you page proofs of your chapter electronically on 10th July, as scheduled, and it is perfectly fine , if you send your comments/corrections for page proofs of your chapter to Dr. Matzke by 22nd July.
Thanks for letting us know that you will not be available on these dates and are fine with the schedule.
Thanks for letting us know that you are not available from 10th May through 14th May. Since we will send you page proofs of your chapter on 14th May, the schedule which we have mentioned below should not be a problem. Please let us know if you want to have additional 1 or 2 days for your review, we will accommodate that in this schedule.
Thanks for letting us know about your plans. Since you would not be available for review until May 21, so can return your corrections/comments for your chapter to Dr. Wells by 29th May instead of 21st May.Hope this is fine with you.
Thanks for letting us know. We will try to send page proofs of your chapter by the 13th. Else you can take 2-3 days extra to review your chapter and return your corrections to Dr. Wells by 24th May. Hope this is fine with you.
Thanks for letting us know your plans. We will try to send you page proofs of your chapter by 1st May if possible, else you can take one more week and can send your comments to Dr. Wells by 28th May instead of 21st May. Please let us know if it is fine with you.
Email address has been updated
Thanks for sharing this information with us. We will send you page proofs of your chapter by 17th May and you need to return corrections/comments by 24th May. Please let us know if it is fine with you.
Thanks for confirming the schedule. We will send you both e-proofs and hard-copy proofs of your chapter. Can you please send us your shipping address?
Thanks for letting us know your updated email address and your plans during this time. We will try to send page proofs of your chapter early if possible. Else since you are not available from 11th June - 14th June, you can take 3-4 days extra and return your corrections/comments for page proofs of your chapter to Dr. Wells by 18th June instead of 14th June. Please let us know if it is fine with you.
Thanks for letting us know about this. As scheduled we will send you page proofs of your chapter by 7th June. In case you need extra time to review it , you can let us know and we will accommodate that in the schedule.
Since you would not be available in the time period when we had initially planned to send you the page proofs , so we have revised the schedule for your chapter. We now plan to send the page proofs of your chapter by 24th April and you need to send your comments to Dr. Wells by 1st May. Could you please confirm if this is fine with you ? Also, we will wait to hear from you regarding identification of colors for Algorithms as mentioned in our email below.
Hard Copy to be sent
Thanks for informing us about this. You can send your corrections/comments for page proofs of your chapter to Dr. Posey by 11th July instead of 14th June. Please let us know if it is fine with you. Thanks for sharing your vacation plans with us. You can take additional days and send comments/corrections for page proofs of your chapter to Dr. Yee by 28th August instead of 16th August. I hope it is fine. Thank you for adjusting the date!
BHR-T
, thanks for confirming the mode of receipt of page proofs of your chapter. It is fine if you send your comments/corrections for page proofs of your chapter to Dr. Matzke by 22nd July instead of 17th July.
Thanks for sharing your vacation plans with us. Since you will not be available from 8/7 to 8/18, you can take one week extra and can send your comments/corrections for page proofs of your chapter to Dr. Posey by 23rd August instead of 16th August. I hope it is fine with you.
Thanks for sharing your travel plans with us. We understand you may not be available in August and possibly when the page proofs of your chapter is due to you. Will it work if we send them to you by 24th July and you can then return your corrections/comments to Dr. Yee by 31st July ? Yes that will work. Thank you for your understanding! Kristen
Thanks for letting us know you are not available August 12-19. Keeping this into account, we will send you page proofs of your chapter by 3rd August, and you need send your comments/corrections to Dr. Yee by 10th August. I hope it is fine with you now.
We will send you the page proofs of your Chapter 88 "Skin and Soft Tissue Infections" and Chapter 100 "Infections in Immunocompromised Patients" by April 8 and you need to send your corrections/comments to Dr. Dipiro by April 15. I hope this is fine with you.
Email Id updated
Can you please confirm the schedule mentioned in our email below is acceptable to you? Per your preference, we will send you electronic files of page proofs of your chapter for review.
We will send you the page proofs of your Chapter 88 "Skin and Soft Tissue Infections" and Chapter 100 "Infections in Immunocompromised Patients" by April 8 and you need to send your corrections/comments to Dr. Dipiro by April 15. I hope this is fine with you.
Thanks for letting us know that you may not be available during this time. Sure, if you can let us know the dates when you are not available, we will make changes to the schedule accordingly and will communicate to you. Please share this information with us at the earliest because this helps us plan the associated activities
Thanks for sharing your vacation plans with us. Since we will be sending page proofs of your chapter on 9th August, we understand you are fine with the schedule. Incase you need an extra day or two for review, please do let us know. Thanks for sharing your plans with us. Since you will not be available from June 7th to June 17th, we understand the below-mentioned schedule is fine with you.
Thanks for letting us know that you will be on vacation August 10-19. You can take one week extra and return comments/corrections for page proofs of your chapter to Dr. Yee by 23rd August instead of 16th August. I hope it is fine with you.
Thanks for sharing your vacation plans and confirming that the schedule is fine with you.
Thanks for sharing your vacation plans with us and letting us know that you are fine with the schedule. We will send page proofs of your chapter per the
We understand you are fine with the e-proofing method.
Thanks for confirming the mode of receipt of page proofs of your chapter. Also, thanks for confirming that the schedule is fine with you. ------Thank you,
Received on 18 June
ondering if I could get the draft sooner such as 7/19? or later on by 8/5?
Dear Author, Thanks for your email and sharing your plans with us. It is fine if you send comments/corrections for your chapter to Dr. Posey by 5th August. I just
on plans the week of July 24-31, so will be able to comply with the deadlines set forth in your email below.
) for this revised chapter so please only send communications to me. The other authors from the last edition did not contribute to this ed
Thanks for your letting us know. This is fine. You can send your comments/corrections for page proofs of your chapter to Dr. Posey by midAugust.
Thanks for sharing your plans with us. You can take a few additional days to complete your review and send your comments/corrections to Dr. Posey by 15th July instead of 10th July. I hope it is fine. -------Thank you. This schedule works for me.
Remarks
Author's email address has been updated on April 29
Hard Copy to be sent to author
Christine A. Sorkness, Pharm.D. University of Wisconsin School of Pharmacy 777 Highland Ave.
For some reason, I have not received your previous emails about this request until Dr Dager emailed me. Im not sure why that happened because I can see that you sent them to me but they did not make it to my Inbox. If we can have time until Friday to send you the feedback, that would be great. Im very sorry about the delay if you could next time in addition cc the emails to my personal e-mail address (halilovic@gmail.com) , that will hopefully avoid this from happening agagin.
2 hard copies to be sent
Karim Anton Calis, Pharm.D., M.P.H., FASHP, FCCP Clinical Reviewer Division of Metabolism and Endocrinology Products Center for Drug Evaluation and Research U.S. Food and Drug Administration WO22, Room 3100 (HFD-510) 10903 New Hampshire Avenue Silver Spring, Maryland 20993 E-mail: karim.calis@fda.hhs.gov Phone: 301-796-5037 Fax: 301-796-9712 Just a quick note to let you know that Dr. Susan R. Davis has elected not to serve as an author of Chapter 65, and thus her name should be removed from the contributor list.
Hi Saloni, thank you very much!! Mary Beth (on 3rd June)
t forth in your email below.
authors from the last edition did not contribute to this edition. Michael can you please correct this? I have been getting questions from
Affiliation
Address
2404 Doral Dr. Blackwood, NJ 08012
Karim Anton Calis, Clinical Reviewer Division of Metabolism and Endocrinology Products Center for Drug Evaluation and Research U.S. Food and Drug Administration WO22, Room 3100 (HFD-510) 10903 New Hampshire Avenue Silver Spring, Maryland 20993, E-mail: karim.calis@fda.hhs.gov
email Id has been updated
19-Jun
18-Jun
Thanks for sharing your plans with us. In which case you can take a few additional days to complete your review and
18-Jun
18-Jun
Ph#
Fx#
Comments
Phone: 301-7965037
Fax: 301-796-9712
2nd Copy to be sent at: Dr. Joseph Jordan, Indiana University Health, 7641 Wickfield Drive I-65 at 21st Street, RM CG04, Indianapolis, IN 46256 Telephone: (317) 962-1438 Telephone: (317) 915-7581 Facsimile: (317) 962-1756 E-Mail: jjordan1@iuhealth.org
Chapte r#/ 1 2 4 10 w13 28 29 30 36 37 120 59 13 57
Chapter Title Cardiovascular Testing Cardiopulmonary Arrest Systolic and Distolic Heart Failure Stroke Cardiovascular Testing Acute Kidney Injury Chronic Kidney Disease: Management of Complications Hemodialysis and Peritoneal Dialysis Potassium and Magnesium Homeostasis Acid-Base Disorders Enternal Nutrition
No of Pages
Hardcopy for Author
Hardcopy for Editor
Total No of Pages
Sent To
Sent On
Sent By
Airway Bill No
Amount (INR)
33 25 44 17 33 28 38 27 19 25 23
No No No No No NO NO NO NO NO NO NO
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
33 25 44 17 33 28 38 27 19 25 23
Dr. Talbert Dr. Talbert Dr. Talbert Dr. Talbert Dr. Talbert Dr. Matzke Dr. Matzke Dr. Matzke Dr. Matzke Dr. Matzke Dr. Matzke Dr. Talbert
16-Mar-13 16-Mar-13 16-Mar-13 16-Mar-13 16-Mar-13 16-Mar-13
Saloni Saloni Saloni Saloni Saloni Saloni
9397113946
1161.25
16-Mar-13 Saloni 16-Mar-13 Saloni 16-Mar-13 Saloni 16-Mar-13 Saloni 3-Apr-13 Saloni 9397109326 1161.25
7994386164
495.68
Adrenal Gland Disorders Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock ENDOCRINOLOGIC DISORDERS Thyroid Disorders Pituitary Gland Disorders Pituitary Gland Disorders Pituitary Gland Disorders
58 60 60 60
NO NO NO NO Yes Yes
Yes Yes Yes Yes No No
Dr. Talbert Dr. Talbert Dr. Talbert Dr. Talbert Karim Anton Calis Dr. Joseph Jordan
10th June 11th June 12th June 13th June 14th June 15th June
Saloni Saloni Saloni Saloni Saloni Saloni
6404195685 6404195685 6404195685 6404195685 6404195700 6404195696
Courier Received
Chapte r no 1 2 4 10 w13 Chapter Title Cardiovascular Testing Cardiopulmonary Arrest Systolic and Distolic Heart Failure Stroke Cardiovascular Testing No Of Pages Received From Date Airway Bill No Amount (INR)
33 25 44 17 33
Dr. Talbert Dr. Talbert Dr. Talbert Dr. Talbert Dr. Talbert
29-Mar-13 29-Mar-13 29-Mar-13 29-Mar-13 29-Mar-13
7474556983
Courier sent to us using TD's import account number.
Revises to be sent Chapter No Chapter title
65 Hormone Therapy in Women 76 Allergic Rhinitis"
Due on
Attached are the 4 files for chapter 65. They are asking for a lot of changes to this chapter. They have deleted quite a bit of material, but also added significant new material. Hopefully the deletions will counterbalance the additions. Nevertheless, I think it would be best to make these changes and then send a second pass page proof to me, Dr. Dang, and Dr. Calis. Drs. Dang and Calis promise a 24-48 hour turn around on the second pass page proofs. No need to bother Dr. Kalantaridou with this second pass. Please try to give Drs. Dang and Calis a heads up in advance so they will know when to expect the second pass page proofs.
There are no changes to the learning objectives file. The MCQ Word file is a clean copy. I hope thats O.K. They have also sent a pdf file of 2 of the tables that you will likely want to refer to in making the changes marked on the page proof of these two tables. 15-Jul Would you mind sending the corrected table to me for one last look? We will send you the revised file of your chapter once it is re
ou the revised file of your chapter once it is ready.

Dipiro Status Report

Transféré par

Informations du document

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

Dipiro Status Report

Transféré par

Droits d'auteur :

Formats disponibles

Sample sent on: 21 Feb Sample Approved on : 26-Feb printer test sent on 26 March,13 printer test approved on : 28th

Typeset Pages (Excluding Blanks)

Inputs Receipt Date

Page Proofs Due on

Sent to Author Sent to editor on on

Matzke Matzke Matzke Wells

99 Invasive Fungal Infections

DiPiro Print 168 130 32 37

15-Mar 2-Apr-13 2-Apr-13 2-Apr-13

100 17 Nutritional Disorders 101 120

Infections in Immunocompromised Patients Antimicrobial Prophylaxis in Surgery Enteral Nutrition

DiPiro DiPiro Matzke

Print Print Print

139 78 152 3384

28-Dec-12 28-Dec-12 12-Jan-13

10-Jan-13 10-Jan-13 14-Jan-13

15th march 15th march 15th march

18-Mar 19-Mar 20-Mar

3-Apr-13 2-Apr-13 2-Apr-13

3-Apr-13 2-Apr-13 2-Apr-13

2-Apr-13 2-Apr-13 2-Apr-13

Wells Wells Wells

69 102 95 30 62 94 43 66 90 64 110 65 102 63 54

Disorders Associated with Intellectual Disabilities ENDOCRINOLOGIC DISORDERS

Print Print Print

11-Mar-13 11-Mar-13 11-Mar-13

20-Mar-13 20-Mar-13 20-Mar-13

5-May-13 5-May-13 5-May-13

25-Apr-13 28-May-13 31-May-13

17-May-13 7-Jun-13 7-Jun-13

17-May-13 7-Jun-13 7-Jun-13

17-May-13 7-Jun-13 7-Jun-13

Urinary Incontinence Rheumatologic Disorders OPHTHALMIC AND OTOLARYNGOLOGICAL DISORDERS

116 128 91 106 102 92 65 77 181 96 131 138 79 48 88 96 97

91 92 93 94 101 102 103 104

21-May-13 23-May-13 8-Apr-13 9-Apr-13 10-Apr-13 11-Apr-13 11-Apr-13 13 June, 13

7-Jun-13 10-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13

7-Jun-13 10-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13 7-Jun-13

Immunologic Disorders Hematologic Disorders

33 34 35 69 70 80 81 82 92 95 97 98 102 103 104 105 106

Matzke Matzke Matzke

Respiratory Disorders Gastrointestinal Disorders

12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 12-Jun-13 11-Jun-13 11-Jun-13

26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 26-Jul-13 25-Jul-13 25-Jul-13

Organ-Specific Function Tests and Drug-Induced Diseases Posey Yee DiPiro

w23(W22) w24(W23) w25(W24)

Revised proofs and index (By TD) proofs to McGraw-Hill due on

Revised pages actually sent on

Final Printer Files due to McGrawHill

Final Printer Files to mcgrawhill actually sent on

Final XML Files Sent Remarks on

schedule is changed as per Editor's confirmation (March 9 - 16)

11-Jun 11-Jun 15-Jun 15-Jun 11-Jun 15-Jun 15-Jun 11-Jun

23-Apr-13 19-Apr-13 Yes

15-Apr-13 9-Apr-13 9-Apr-13

16-Apr-13 7-Apr-13 10-Apr-13

23-Apr-13 23-Apr-13 23-Apr-13

19-Apr-13 19-Apr-13 12-Apr-13

Yes Yes Yes

27-May-13 27-May-13 27-May-13

schedule changed/ author will send correction to editor by April 15 20-Jun

13-Jun 24-May-13 5-Jun-13 27-May-14 21-May-13 27-May-14 5-Jun-13 22-May-13

yes yes yes yes yes yes yes yes

24-May-13 14-Jun-13 14-Jun-13